Podcasts about Io

brianturnershow.com, eastvillageradio.comLOOP - Got To Get It Over - Fade Out (Chapter 22, 1988)CULT FIGURES - Zip Nolan - Live Cedar Club 1980 (Topplers, 2009)THE EDUCATED FOOLS - The Geyser - Tantric Decapitation: 69 Mins of Trichotomy and Liquefaction (NL, 2025)BÉTON ARMÉ - Pendule à L'heure - Demos 2018 (Shoom/Primator Crew, 2018)AVENIR - Petal - Primitive Maxi Trial (Heat Crimes, 2025)HOME SECRETARY - The Singer Said This One Was About Hagfish But Was Actually Thinking About Cigar Sharks - Things! (Chocolate Monk, 2025)TOO MANY ROCK STARS HATE EACH OTHERTUNE ZITOUNE - Haragarider - Ouais Enfin Voilà Quoi (La Face Cachee, 2025)MARC RILEY - Wanted Man - V/A: Til Things Are Brighter: A Tribute To Johnny Cash (Red Rhino, 1988)SACRED LODGE -  WWa Ke Wa Wa Yi (Feat. Sara Persico) - Ambam (Avor Terror Corps, 2025)XEROXHEAD - Batterie Gelée - I/O (cs, Un Poco Fría, 2025)AUFGEHOBEN - Anno Fauve - Anno Fauve (Riot Season, 2004)GREY DATURAS - Beyond and into the Ultimate - Return To Disruption (Neurot Recordings, 2008)NAOKI ZUSHI - Yearning of Flowers - III (2005, re: World of Echo, 2025)SIR RICHARD BISHOP - They Shall Take up Serpents - Hillbilly Ragas (Drag City, 2025)CCR DOG - Fortunate DogSAVOY HAVANA BAND - I'm Gonna Bring a Watermelon to My Girl Tonight - V/A: Songs The Bonzo Dog Band Taught Us (Voiceprint, 2009)ATMO - Zeitfenster - Brechen (cs, Latenz, 2025)BRUCE SINGS ABOUT DADDY A LOTMENTOCOME - 12 - Mentocome (1992, re: Amok Age, 2025)A SET FOR JOHN WHITSON:BLUES CONTROL - Frankie's Problem - Blues Control (Holy Mountain, 2007)ALEJANDRO MEDINA Y LA PASADA - Un Estado Natural - Alejandro Medina Y La Pasada (1974, re: Mondo Svart, 2020)THE ROLLING STONES - Happy - Will Keith Wake Up In Time For the Afternoon Show in Perth Australa 24/2/1973?? (Human Riff)AINOTAMENISHIS - I Don't Smoke It - Live '418 (Holy Mountain, 2007)ONNA - Were You To Become a Mother - Onna (Holy Mountain, 2009)LES RALLIZES DÉNUDÉS - Reapers of the Night - Baus '93 (Temporal Drift, 2023)

Your strengths aren't just what you're good at—they're your career compass. When you ignore your signature strengths, even great opportunities become draining. Discover how one IO psychologist used her strengths to break free from the "great opportunity trap" and find work that truly energizes her.   What you'll learn Why your signature strengths should guide your career experiments and decisions How to get valuable feedback from friends and family about your natural talents The difference between skills you can do versus strengths that energize you   Our book, Happen To Your Career: An Unconventional Approach To Career Change and Meaningful Work, is now available on audiobook! Visit  happentoyourcareer.com/audible to order it now! Visit happentoyourcareer.com/book for more information or buy the print or ebook here! Want to chat with our team about your unique situation? Schedule a conversation   Free Resources What career fits you? Join our free 8 Day Mini Course to figure it out! Career Change Guide - Learn how high-performers discover their ideal career and find meaningful, well-paid work without starting over.   Related Episodes Discover Your Strengths to Find Your Ideal Career (Spotify / Apple Podcasts) Should I Quit My Job? How to Know It's Time (Spotify / Apple Podcasts)

Hon är Italiens första kvinnliga premiärminister, en fantasyälskande populist som har ifrågasatts för sina kopplingar till landets mörka historia. Nya avsnitt från P3 ID hittar du först i Sveriges Radio Play. ”Io sono Giorgia, sono una donna, sono una madre!” – ”Jag är Giorgia, jag är kvinna, jag är mamma, jag är italienare, jag är kristen. Det kan de aldrig ta ifrån mig!”Orden ekar ut över en enorm folkmassa på Piazza San Giovanni i Rom hösten 2019. Vid talarpodiet står en kort kvinna med blont hår, ledigt klädd i mörka byxor och en fladdrig ljusgrå blus.Trots att hon är flankerad av flera politiska tungviktare så är det Giorgia Meloni, partiledare för Italiens bröder, som stjäl showen den här dagen. Hennes eldiga ord blir det politiska manifest som kommer att bära Meloni och hennes parti till valseger några år senare.Giorgia Melonis politiska resa inleds i början på 90-talet, när hon som 15-åring ringer på dörren till Fronte della Gioventù, det politiska partiet Movimento Sociale Italianos ungdomsförbund.Det är ett parti som grundades av den fascistiske diktatorn Benito Mussolinis anhängare, och som vid den tiden befinner sig på utkanten av det italienska etablissemanget på grund av de historiska banden till en tid som präglades av skräck och våld.P3 ID om Giorgia Meloni följer hennes utveckling från blyg tonåring med en gnagande känsla av att något är fel i det italienska samhället, till retorisk pitbull som inte räds någon motståndare på den politiska arenan.I avsnittet medverkar Eskil Fagerström, journalist på Sydsvenskan och författare till flera böcker om det moderna Italien, Giulia Kappelin Cingolani, journalist baserad i Italien, och Filip Jacobson, utrikesreporter på TV4.Klippen i avsnittet är hämtade från Rai, Right Side Broadcasting Network, Giorgia Melonis Facebooksida, Fratelli d'Italias Youtubekanal, Wine News, Diario AS, VOA Africa, Vista Agenzia Televisiva Nazionale, Vita husets Youtubekanal, British Pathé, La7 Attualità.

- Premere il tasto PLAY per ascoltare la catechesi del giorno -+ Dal Vangelo secondo Matteo +In quel tempo, Gesù, vide un uomo, chiamato Matteo, seduto al banco delle imposte, e gli disse: «Seguimi». Ed egli si alzò e lo seguì.Mentre sedeva a tavola nella casa, sopraggiunsero molti pubblicani e peccatori e se ne stavano a tavola con Gesù e con i suoi discepoli. Vedendo ciò, i farisei dicevano ai suoi discepoli: «Come mai il vostro maestro mangia insieme ai pubblicani e ai peccatori?».Udito questo, disse: «Non sono i sani che hanno bisogno del medico, ma i malati. Andate a imparare che cosa vuol dire: “Misericordia io voglio e non sacrifici”. Io non sono venuto infatti a chiamare i giusti, ma i peccatori».Parola del Signore.

Federica Falzea ha 43 anni, vive a Milano ma è nata e cresciuta a Lecce in una famiglia dove l'istruzione è sempre stata il vero motore di riscatto sociale. Figlia di due medici, Federica sceglie un approccio più olistico alla cura: va a studiare osteopatia a Milano, trovando alloggio presso una congregazione di suore, dove per la prima volta entra in contatto con la vita religiosa. Dopo quattro anni di studio, la svolta. Decide di lasciare la scuola per entrare in convento, dove trascorre nove anni studiando Psicologia Giovanile e Teologia. Col tempo, però, la spinta iniziale inizia ad affievolirsi e Federica decide di lasciare la vita religiosa per riprendere gli studi di osteopatia. In tre anni conclude la scuola, apre uno studio, si sposa e ha due figli.Tutto procede bene fino al 2022, quando le viene diagnosticato un tumore al peritoneo. Durante l'intervento le vengono asportati anche utero e ovaie e, dopo l'operazione, cominciano sintomi molto potenti: confusione, sbalzi d'umore, sudorazione e insonnia, inizialmente attribuiti all'intervento.Nella casa di cura dove è stata operata, nessuno la informa che la rimozione degli organi riproduttivi avrebbe causato una menopausa chirurgica precoce. Solo in seguito, grazie alla sua ginecologa, arriva la diagnosi corretta e l'inizio della terapia ormonale sostitutiva, la TOS. Federica sta meglio, ma si ritrova ad affrontare un nuovo ostacolo: i costi.La terapia, infatti, è tutta a carico suo. Tra farmaci, pomate specifiche e fisioterapia riabilitativa legata ai sintomi della menopausa, la spesa arriva facilmente a superare i 3.000 euro all'anno. Una cifra significativa, soprattutto se si considera che molte di queste cure non sono un “di più”, ma un'esigenza per continuare a vivere bene. I costi della menopausa non si fermano però alle terapie: si riflettono anche sul lavoro. Le donne affrontano questo passaggio fisiologico nel momento di massima responsabilità e rendimento professionale. Secondo uno studio anglosassone, ogni anno le donne in menopausa si assentano dal lavoro per una media di 24 ore, causando una perdita economica stimata in 15 milioni di euro. E se lavori in proprio, come Federica, il prezzo si misura in termini di mancato guadagno: «Io, da agosto del 2022, dopo circa cinque mesi, ho ripreso a lavorare. Cinque mesi senza alcuna entrata, senza alcun guadagno».Così, per contrastare anni di invisibilità e disinformazione, Federica e un'amica, Silvia, decidono di dare vita a MenoP: un progetto che vuole rompere il tabù attorno alla menopausa e dare finalmente voce a un'esperienza femminile ancora troppo spesso ignorata. Insieme organizzano focus group e incontri nelle aziende, portando formazione e consapevolezza dove ancora mancano strumenti e parole: «Cerchiamo di offrire una narrazione della menopausa diversa da quella che ci viene solitamente proposta, una narrazione in cui possiamo davvero riconoscerci e sentirci coinvolte».

Help MuggleCast grow! Become a MuggleCast Member and get great benefits like Bonus MuggleCast! Patreon.com/MuggleCast  Grab official merch! MuggleCastMerch.com Pick up overstock merch from years past, including our 19th Anniversary Shirt! MuggleMillennial.Etsy.com On this week's episode, break out the scantrons and No. 2 pencils because Harry, Ron and Hermione are finally sitting their O.W.L.s. Join Andrew, Eric, Micah, Laura and Slug Club member Stacy for the stress-inducing conclusion to Harry's fifth year at Hogwarts. And if exams weren't enough, Hagrid's been sacked and Voldemort has Sirius! Welcome Slug Club member, Stacy! Chapter-by-Chapter continues with Harry Potter and the Order of the Phoenix, Chapter 31: O.W.L.s. Our Time Turner segment takes us back to Episode 468 of MuggleCast, titled “Rubeus Hagrid's Punch Out.”  Ron cannot stop talking about his big Quidditch win! Did we ever have a friend who just wouldn't shut it about a big accomplishment? Magical Moment: Ron reminds Harry of his father James After learning about Grawp, Ron raises a fantastic point: “Have we ever come off better for mixing with one of Hagrid's monster mates?” How do the O.W.L. exams reflect real-world academic pressures? Draco drops some real world knowledge: "It's not what you know, but who you know!" Why do the students have to wait until July for their scores? Shouldn't magic allow for instant results? Wingardium Leviosa, Polyjuice Potion & Patronuses! During Harry's O.W.L.s, we get several throwbacks to the first three books! Speaking of Patronuses, is Professor Tofty playing favorites? Does he offer the other students bonus points? What does the nighttime ambush of Hagrid suggest about the Ministry's tactics? Sirius Problem: Voldemort has Harry's godfather in the Department of Mysteries! What would Harry's post-exam life look like if he didn't have a Dark Lord inside of his head? The hosts share which O.W.L. they would most like to sit! Harry overhears Professor Marchbanks tell Professor Umbridge that Dumbledore “Did things with a wand I'd never seen before!” In our Lynx Line segment for the week, we ask our Patrons what kind of things do you imagine Dumbledore doing to impress the examiners? Quizzitch: Harry struggles to name all of the moons of Jupiter for his Astronomy O.W.L. WHICH of the FOLLOWING is NOT one of Jupiter's moons? Io, Metis, Europa, Ganymede, Calypso, Themisto, Pandia, and S/2003 J 2. Join in on the fun! Tilda Swinton? Peter O'Toole? James McAvoy? Michael Cera!? On this week's Bonus MuggleCast, we discuss the actors who turned down Harry Potter roles!   Learn more about your ad choices. Visit megaphone.fm/adchoices

The AI drama is full tilt!↳ Meta and OpenAI have all but declared a war on top tech talent. ↳ Google released a free AI coding tool that will likely make huge cuts into Claude's customer base. ↳ Salesforce says AI is doing their own jobs for them. And that's just the tip of the AI iceberg y'all. Don't waste hours a day trying to keep up with AI. Instead, join us on Mondays as we bring you the AI News That Matters.Newsletter: Sign up for our free daily newsletterMore on this Episode: Episode PageJoin the discussion: Thoughts on this? Join the convo.Upcoming Episodes: Check out the upcoming Everyday AI Livestream lineupWebsite: YourEverydayAI.comEmail The Show: info@youreverydayai.comConnect with Jordan on LinkedInTopics Covered in This Episode:AI Talent War: Meta vs. OpenAIAI Firms and Copyright Lawsuits UpdateOpenAI Trademark Battle with IOEleven Labs' New Voice AI LaunchUS Senate AI Regulation DealAnthropic's Claude Platform Features UpdateSalesforce's AI Workload IntegrationGoogle Gemini CLI Free Coding ToolMeta's Aggressive AI Talent RecruitmentOpenAI's Strategy to Retain ResearchersTimestamps:00:00 "AI News: Weekly and Daily Updates"03:12 AI Copyright Lawsuits: Early Rulings09:18 OpenAI-IO Trademark Dispute Unveiled12:23 Futile Lawsuit Against New Gadget14:21 "11 AI: Voice-Activated Task Assistant"17:37 "AI Strategy and Education Solutions"21:54 Federal AI Funding and State Regulation25:05 States Must Forego AI Regulation28:18 Anthropic Updates Claude with Artifacts31:23 Claude vs. Google Usage Limits37:17 Google Disrupts Coding with Free Tool40:17 Meta's AI Talent and Business Strategy44:20 OpenAI Responds to Meta Poaching45:49 AI Developments: LLaMA and Grok Updates49:14 OpenAI Faces Lawsuit Over IOKeywords:AI talent war, Meta, OpenAI, Federal judges ruling, California federal judges, Copyrighted books, Anthropic, Meta's legal win, Sarah Silverman, US Supreme Court, Intellectual property rights, New York Times vs OpenAI, Disney lawsuit, Universal lawsuit, Midjourney, State AI regulation, Federal funding, US Senate, Ten-year ban, Five-year ban, AI infrastructure, Federal AI funds, Sam Altman, IO hardware startup, Trademark battle, Hardware device, Eleven Labs, 11 AI, Voice assistant, Voice command execution, MCP, Salesforce, Marc Benioff, AI workload, AI agents, Anthropic Claude update, Artifacts feature, Artifact embedding, Salesforce customer service, Command line interface, Gemini CLI, Gemini 2.5 pro, Coding tools, Desktop coding agent, Meta poaching, Superintelligence lab, AI researchers, Meta's aggressive recruitment, Llama four, Llama 4.5, Microsoft, Anthropic, Google Gemini scheduled tasks, GoogleSend Everyday AI and Jordan a text message. (We can't reply back unless you leave contact info) Ready for ROI on GenAI? Go to youreverydayai.com/partner

Crash DMs for Beth, Ellie, Io, Jen, & Milly. Not every empty town is abandoned, or actually empty. Follow this series on… ▶RSS: https://aaronbsmith.com/cogwheel/tag/cause-and-effect/feed/ ▶Patreon: https://www.patreon.com/cogwheelgaming ▶Mastodon: https://is.aaronbsmith.com/@cogwheel MP3 Download: Cause & Effect Ep 59: Mountain Town Music Used: “Pandora's Box (FB Mix)” by christofori is licensed as Public Domain and can be downloaded from … Continue reading "Cause & Effect Ep 59: Mountain Town"

ChatGPT Show Notes: In this energizing and insightful episode, John and Doubting Thomas wrap up their discussion on the dangers of digital distractions and the power of purposeful living. Against the laid-back backdrop of a mellow bar, the conversation dives into practical strategies for reclaiming focus, defining meaningful goals, and resisting the pull of clickbait content. Through relatable dialogue, poetic reminders, and heartfelt reflection, this finale encourages listeners to take back their time — one mindful choice at a time.

Rejoignez la communauté iWeek et soutenez-nous sur patreon.com/iweek !Voici l'épisode 238 d'iWeek (la semaine Apple), le podcast avec ses chapitres !iPhone 17 Pro et iPhone 17 Pro Max : les quatre nouveautés photo-vidéo attendues.Enregistré samedi 28 juin 2025 à 11h45, enregistrement accessible en direct sur X, YouTube et LinkedIn Live. Un épisode châpitré : profitez-en !Présentation : Benjamin Vincent avec la participation de Gilles Dounès, ex-rédacteur en chef de MacPlus et co-auteur de “iPod backstage“ (Dunod).Au sommaire de cet épisode 238 : La nouvelle gamme iPhone 17 devrait être dévoilée par Apple à la rentrée et donc dans un peu plus de deux mois. A l'approche de la keynote de septembre, les rumeurs se multiplient sur les caractéristiques des nouveaux iPhone et notamment des deux modèles “Pro“ : l'iPhone 17 Pro et l'iPhone 17 Pro Max avec, cette semaine, plusieurs précisions sur les rumeurs qui concernent les quatre nouveautés majeures attendues pour la partie audio-vidéo : c'est l'info de la semaine.L'événement de la semaine ne concerne pas directement Apple, quoi que... puisqu'il s'agit d'IA et de la décision d'un tribunal de Californie après plainte contre Anthropic, l'éditeur de Claude, concurrent de chatGPT. Le tribunal a estimé que l'utilisation d'oeuvres protégées par le droit d'auteur pour entraîner l'IA d'Anthropic... relevait de l'usage équitable, autrement dit d'utilisations sans autorisation mais dans un cadre légal. Le jugement pourrait faire jurisprudence et on s'en inquiète, évidemment.Plusieurs infos au programme du JT de la semaine : l'iPhone 17 Air quasiment confirmé dans du code Apple, des détails sur son probable système de refroidissement qui serait une première sur iPhone, une référence au AirTag 2 dans iOS 18.6, des détails sur l'Apple Watch Ultra 3 avec une date de disponibilité potentielle à la rentrée et, enfin, un rappel de cinq batteries par Anker face à un risque d'incendie.Enfin, chers soutiens, nous l'enregistrons pour vous : le bonus hebdo exclusif. Cette semaine, suite du "retour sur" déjà consacré à la forme que pourrait prendre le premier produit chatGPT imaginé par Jony Ive et Sam Altman : dans le bonus, nous revenons sur le rétropédalage opéré par OpenAI à propos de l'acquisition de "IO", la startup de Jony Ive (pour 6,4 milliards de $) : toute mention du rapprochement a disparu du site d'OpenAI à cause d'une bataille judiciaire aux Etats-Unis à propos de la propriété de la marque, contestée par une autre entreprise, "iyO", avec laquelle plusieurs membres de l'équipe d'IO avaient été en contact.À mardi prochain, 1er juillet pour l'épisode 239 dont l'enregistrement sera à suivre en direct sur sur X, YouTube et LinkedIn Live à un horaire probablement plus tardif que d'habitude : nous vous le préciserons ici et sur X d'ici là.Hébergé par Ausha. Visitez ausha.co/politique-de-confidentialite pour plus d'informations.

ぬるぽ放送局おたより投稿フォーム https://forms.gle/6tbmBzK6wbyavJG47 2025年6月パワープレイ 01. Stay Foolish 編曲：D.watt 原曲：東方紅魔郷 / おてんば恋娘 収録アルバム：TOHO BOOTLEGS 9 2025・5・5 Release https://www.iosysos.com/discographyportal.php?cdno=IO-0341 番組時間：79分20秒 出演者：夕野ヨシミ、たくや VOICEVOX:ずんだもん VOICEVOX:四国めたん ---- 2025/6/26に公開録音したものを配信いたします。 ラジオ記事はリスナーのEEチャンピオンさんが書いてくれているので楽してます。 ＜オープニング＞ ・自分の番組の名前が出てこないと終わりよ ・金八先生が始まるのかと思った ・金八先生そんなに前なの？ ・定年して、ちゃんとおわったんだ ・はじめての告知からやります ・今週のベスト10 ・たくさん人が来てた北海道ご当地キャラフェスタ ・楽曲提供のお知らせ 　「つよつよナースブロウちゃん！」 - Muse Dash 　歌唱：まるもこ 　作編曲：コバヤシユウヤ(IOSYS) 　作詞：john=hive(IOSYS) 　ギター：三浦公紀 ・ジョン…ハイヴ！ ・正解 ・作詞提供のお知らせ 　ブルーアーカイブ 青春あんさんぶる Vol.12「ヴァルキューレ」 　「パトランプハーモニー！」 　アーティスト：カンナ／キリノ／フブキ 　作詞：夕野ヨシミ(IOSYS) 　作曲：Nor ・ブルーアーカイブ 絆ダイアローグ Vol.12「ヨシミ」 　「イマハカラメル―Sweeten Up Later」 　アーティスト：ヨシミ 　作詞：夕野ヨシミ(IOSYS) 　作曲：KARUT　 ・ダブルヨシミです ・「憧れの日々」 　アーティスト：フウカ(CV:ファイルーズあい) 　作詞：john=hive(IOSYS) 　作曲：EmoCosine ・ブルアカは3曲出ました ・CD欲しい人はお早めに ・イオシス君やってるねー ・ゲーム『東方ダンマクカグラ ファンタジア・ロスト』DLC12 　「オーディエンスを沸かす程度の能力 feat.タイツォン」 　編曲：D.watt(IOSYS) 　2025/11/27配信 ・あれ、あずきバーなんだ ・ゴブリン・ノーム・ホーンの2回目は、ないんだ ・来週は2本撮りです ・「リスアニ！Vol.58『ブルーアーカイブ -Blue Archive-』キャラクター＆ミュージックガ　イド」 　いろんな方のインタビューが掲載されていますが、作詞家として夕野ヨシミのインタビューも掲載されています！ ・このままエンディングに行っちゃいそう ＜Aパート＞ ・昔のCMを引っ張ってきました ・MOCさんの声聞きたいなー ・ふつおたです ・ToHeartのリメイク版 ・ギャルゲー大好きフワモコちゃん ・農機屋さんの話 ・忙しいです ・需要に生産が追いつかない ・イオシスライス ・バケツで米を育てる ・​​籾摺りご用命はぜひ ・えんぴつ削りを魔改造 ・1年に1回しか使わないならリースすればいいのでは ・知らない人がトップになるのは… ・自動操舵は大事 ・ウッド村さんの最近の農業の話 ・やらしい話聞きたいよね ・鉄腕DASHが続くのはヨシ！ ・熱中症には気を付けようね ・TOKIO解散しちゃったね ・じぎゃくさんお誕生日おめでとうございます ・ロンドンブーツ解散しちゃったね ・ラジオは、もっと自由に ・キーワードはガールズバー ・ガールズバーは卒業？ ・最近はラウンジに行ってます ・ぬるぽはスナックなんだ ・もし、高級だとしたら ・名曲なのにマイナーな曲 ・リメイクの方はお持ち帰りで ・ダンスモーションの配布がしたい ・技術だけは蓄積されてるんだよな ・外で撮るのは恥ずかしかった ・7月は暇なので、いろいろやってみよう ＜Bパート＞ ・あいよ！ ・mikoおねえさんは、すごいあっちこっちで出演してますね ・みつをたです ・梅雨明けてないじゃないですか！やだー！ ・ガルマをなぜ出さない ・予定納税46万円 ・シャア専用ヅダ ・最終回は水着回 ・みこち「ご報告があります」 ・マチュからだった ・リアルタイムに見るのはいい ・あとはみなさん同人誌で ・来週から何を見たら ・Nintendo Switch2をやりましょう ・ランキングのコーナー ・実際に食べてみたい丼物 ・第1位　橘姉妹丼（ブルアカ） ＜エンディング＞ ・最近、美味しい海鮮丼食べました ・ウニ食べたいなー ・カンジャンケジャン食べました ・奥さんと娘と食べてきました ・父さんは引きこもり ・明日は、すってはっくん ・いつもの工場ゲームです ・ゲームのDEMO版を3つ用意してます ・今年も半分おわります ・7,8,9月は余裕、余裕 ・エンディングを持て余してる ・空っぽのエンディングです ・ファンボックス5周年です ・も、もうなんもないっす ・イオシスショップセールやります ・成人は18歳なのかい？ ・期日前投票に10回くらい行こう ・あの投票所何度も投票できるみたいですねー ・壁抜け投票バグ ・​​投票所をホットプレートで温める ・これ以上は利用契約に違反しちゃう

Oggi a Cult: Marco D'Eramo sulla riedizione di "Io sono un'aliena" (Feltrinelli) di Luce D'Eramo; la mostra alle Gallerie d'Italia di Milano "Tutti pazzi per i Beatles"; a Trieste il Short Film Festival; la rubrica di fumetti di Antonio Serra con la celebre lista di fumetti per sopravvivere all'estate...

This week, we're cutting to the chase on the latest in AI, from legal battles to the impact on our brains.Here's what's in store:AI News: June 19-25 – A quick hit on the week's key headlines. 4/10A Call for Guests: If you want to be on the show, stand out! Learn how to pitch effectively and avoid the "AI-generated slop" pile.Midjourney's New Video Tools: Turn your still images into dynamic videos with new animation modes, motion intensity control, video extensions, and even external image support.The OpenAI vs. Google "IO" Showdown: Dive into the bombshell lawsuit surrounding OpenAI's $6.5 billion acquisition of Jony Ive's "Altman IO" and the trademark infringement battle with Google-backed "the original IO." Accusations include secret tracking, product purchases, and alleged threats from Sam Altman to force a name change.ChatGPT's App Store Dominance: ChatGPT's downloads nearly rival the combined might of TikTok, Facebook, Instagram, and X.Are LLMs Making Us Dumber? We'll tackle the MIT research linking ChatGPT use to cognitive decline. Plus, we'll discuss how readily available answers affect our critical thinking and the long-term implications for the next generation. As Balaji says, "AI doesn't do it end-to-end. It does it middle-to-middle. The new bottlenecks are prompting and verifying."

Meet the incredible Rebecca Sohn! She is originally a New Jersey girl but has had so many adventures since leaving home at age 18. She describes her father and how he fostered her creativity by building a stage in their basement for her to give dancing performances. Her dad involved the whole family in co-writing a play, which was basically improvised and was produced at two local schools. Her passion and love was ballet until age 16 when she tragically "grew out of a dancer's body" and gave up her dream of being the Prima Ballerina of the World. She remembers her high school English teacher, Ms Bartow, who nurtured her students' artistic sides. At 18 she moved to Boston and recalled seeing an Improv Touring Company Show, but didn't walk away thinking “This is what I want to do.” A few years later she moved to the Bay Area of California and was able to attend school and knew she wanted to be an actor. But the acting classes were full so she enrolled in an improv class, with the thought it would help her acting. While in SF she met Charna Halpern of the IO and was invited to Chicago and the rest was history! It was Charna who persuaded her to date Rebecca's (now) husband, Rich Sohn! To learn more you'll have to listen to the podcast. You can find out even more about Rebecca at her website www.rebeccasohn.com

Ahmad Shadid is the Founder and CEO of O.XYZ, an ecosystem with a mission to build the world's first sovereign super intelligence. As Ahmad put it, "AI must be a tool for the people, not a weapon for profit." O.XYZ is a complex ecosystem, starting with it's core – O.Super Intelligence which will help guide decisions, solve complex problems, and interact with people in the ecosystem; a toolbox with AI-powered products — tools that help you solve various problems using artificial intelligence; O.REASEARCH, O.INFRA, O.CHARITY, O.CAPITAL, and O.CHAIN as parts of the ecosystem.Previously, Ahmad was CEO of IO.net, leading the company to a $4.5 billion valuation in under a year. His leadership propelled IO.net to secure $2 million in a seed round with a $10 million fully diluted valuation in June 2023, followed by a groundbreaking $40 million Series A round at a $1 billion FDV in March 2024. This rapid growth culminated in the successful launch of the $IO coin on Binance, with a remarkable $4.5 billion FDV in June 2024.Ahmad is a visionary behind the DeAIO – an Autonomous AI Organization, the next step in the evolution of DAOs aiming to revolutionize AI governance and development. Demonstrating his commitment to innovation, he has personally invested $130M into the development of DeAIO. O.XYZ builds on Ahmad's legacy, aiming to redefine AI and showcase how decentralized technology can drive common progress and serve people.In this conversation, we discuss:- Creating the First AI CEO- O.CAPTAIN- The future of AI & Crypto - Flipping the Narrative: AI that Helps, Not Replaces- Your EGO vs AI - Security ops and code review will become increasingly important - The feeling of working for AI and not a person  - Building a company fully managed by AI - Living in Doha, Qatar- The future of AI & Crypto - An AI CEO that adapts workloads based on your energy and well-beingO.XYZWebsite: www.o.xyzX: @o_fndnTelegram: t.me/oxyz_communityAhmad ShadidX: @shadid_ioLinkedIn: Ahmad Shadid--------------------------------------------------------------------------------- This episode is brought to you by PrimeXBT. PrimeXBT offers a robust trading system for both beginners and professional traders that demand highly reliable market data and performance. Traders of all experience levels can easily design and customize layouts and widgets to best fit their trading style. PrimeXBT is always offering innovative products and professional trading conditions to all customers.    PrimeXBT is running an exclusive promotion for listeners of the podcast. After making your first deposit, 50% of that first deposit will be credited to your account as a bonus that can be used as additional collateral to open positions. Code: CRYPTONEWS50This promotion is available for a month after activation. Click the link below:PrimeXBT x CRYPTONEWS50

Kovi and Benjamin got together for slice at Jupiter Pizza. They loved the menu - some wood fired pizza options were the Cassiopeia, the Io, Galileo, Gaia, Mercury, Ares, and Triton. As fun as those names are, they pissed off Benjamin something royal. You see, the names are all spacey, yes, but pick a theme! We've got some planets (Ares was the Greek name fo the planet we now call Mars), random moons (from different worlds, mind you), an explorer, a constellation... It's all over the place! The eatery is called Jupiter Pizza - you'd think they'd have, at the very least, four pies named after the Galilean moons Io, Europa, Ganymede and Callisto. Nope! They didn't even refer to pepperoni as 'great red spots' - and that's just off the top of the head! Anywho, this episode was thought up in a pizzeria called Jupiter - so let's talk about places here on Earth named after places in space!

- Premere il tasto PLAY per ascoltare la catechesi del giorno -+ Dal Vangelo secondo Luca +In quel tempo, Gesù disse ai farisei e agli scribi questa parabola:«Chi di voi, se ha cento pecore e ne perde una, non lascia le novantanove nel deserto e va in cerca di quella perduta, finché non la trova?Quando l'ha trovata, pieno di gioia se la carica sulle spalle, va a casa, chiama gli amici e i vicini e dice loro: "Rallegratevi con me, perché ho trovato la mia pecora, quella che si era perduta".Io vi dico: così vi sarà gioia nel cielo per un solo peccatore che si converte, più che per novantanove giusti i quali non hanno bisogno di conversione».Parola del Signore.

Beth GMs for Ellie, Crash, and Io. This episode: The Logistics Trio Find another altered acolyte, and negotiations break down. Follow this series on… ▶ RSS: https://aaronbsmith.com/cogwheel/tag/gurpswars/podcast ▶ Patreon: https://www.patreon.com/cogwheelgaming ▶ Mastodon: https://is.aaronbsmith.com/@cogwheel MP3 Download: GURPS Wars S1 Ep 66: Worst Puppy Music Used: “Cabin Fever!” by Drozerix is licensed as Public Domain and can … Continue reading "GURPS Wars S1 Ep 66: Worst Puppy"

A massive repository of information about OpenAI and Altman just dropped, our take on the man who tried to marry his AI assistant, your calls, and a lot more.

Automakers, tech giants, and others push back against Trump's proposed 25% chip tariff.It's reported that the US strikes on Iran's nuclear facilities in Fordow and Natanz actually only set Iran's nuclear program back about 3-6 months. Sam Altman leaks emails between him and IYO founder Jason Rugolo ahead of their legal battle over OpenAI's IO.And we got a special funding announcement from a company creating new digital minds.Featured Guests: Rob Biederman, Managing Partner, Asymmetric Capital Partners and Dara Ladjevardian, Co-founder and CEO, DelphiDOWNLOAD PUBLIC: ⁠https://public.com/ventureInvest in everything—stocks, options, bonds, crypto. You can even earn some of the highest yields in the industry—like the 7% or higher yield you can lock in with a Bond Account. Public is a FINRA-registered, SIPC-insured platform that takes your investments as seriously as you do. Fund your account in five minutes or less at ⁠⁠(https://public.com/venture?utm_source...) and get up to $10,000 when you transfer your old portfolio.All investing involves the risk of loss, including loss of principal. Brokerage services for US-listed, registered securities, options and bonds in a self-directed account are offered by Public Investing, Inc., member FINRA & SIPC. Public Investing offers a High-Yield Cash Account where funds from this account are automatically deposited into partner banks where they earn interest and are eligible for FDIC insurance; Public Investing is not a bank. Cryptocurrency trading services are offered by Bakkt Crypto Solutions, LLC (NMLS ID 1890144), which is licensed to engage in virtual currency business activity by the NYSDFS. Cryptocurrency is highly speculative, involves a high degree of risk, and has the potential for loss of the entire amount of an investment. Cryptocurrency holdings are not protected by the FDIC or SIPC. A Bond Account is a self-directed brokerage account with Public Investing, member FINRA/SIPC. Deposits into this account are used to purchase 10 investment-grade and high-yield bonds. The 7%+ yield is the average, annualized yield to worst (YTW) across all ten bonds in the Bond Account, before fees, as of 5/15/2025. A bond's yield is a function of its market price, which can fluctuate; therefore, a bond's YTW is not “locked in” until the bond is purchased, and your yield at time of purchase may be different from the yield shown here. The “locked in” YTW is not guaranteed; you may receive less than the YTW of the bonds in the Bond Account if you sell any of the bonds before maturity or if the issuer defaults on the bond. Public Investing charges a markup on each bond trade. See our Fee Schedule (https://public.com/disclosures/fee-sc...)*Terms and Conditions (https://help.public.com/en/articles/6...) apply.

Dr. Vamsi Velcheti and Dr. Nate Pennell discuss novel treatment approaches in small cell and non-small cell lung cancer that were featured at the 2025 ASCO Annual Meeting. TRANSCRIPT Dr. Vamsi Velcheti: Hello, I'm Dr. Vamsi Velcheti, your guest host of the ASCO Daily News Podcast. I'm a professor of medicine and chief of hematology and oncology at the Mayo Clinic in Jacksonville, Florida. The 2025 ASCO Annual Meeting featured some exciting advancements in small cell lung cancer, targeted therapies for non-small cell lung cancer, and other novel [treatment] approaches. Today, I'm delighted to be joined by Dr. Nate Pennell to discuss some of the key abstracts that are advancing the lung cancer field. Dr. Pennell is the co-director of the Cleveland Clinic Lung Cancer Program and also the vice chair of clinical research at the Taussig Cancer Institute. Our full disclosures are available in the transcript of this episode. Nate, it's great to have you back on the podcast. Thanks so much for being here. Dr. Nate Pennell: Thanks, Vamsi. Always a pleasure. Dr. Vamsi Velcheti: Let's get started, and I think the first abstract that really caught my attention was Abstract 8516, “The Randomized Trial of Relevance of Time of Day of Immunotherapy for Progression-Free and Overall Survival in Patients With Non-Small Cell Lung Cancer.” What are your thoughts about this, Nate? Dr. Nate Pennell: I agree. I thought this was one of the most discussed abstracts, certainly in the lung cancer session, but I think even outside of lung cancer, it got some discussion. So, just to put this in perspective, there have been a number of publications that have all been remarkably consistent, and not just in lung cancer but across multiple cancer types, that immunotherapy, immune checkpoint inhibitors, are commonly used. And all of them have suggested, when looking at retrospective cohorts, that patients who receive immune checkpoint inhibitors earlier in the day – so in the morning or before the early afternoon – for whatever reason, appear to have better outcomes than those who get it later in the day, and this has been repeated. And I think many people just sort of assumed that this was some sort of strange association and that there was something fundamentally different from a prognostic standpoint in people who came in in the morning to get their treatment versus those who came later in the afternoon, and that was probably the explanation. The authors of this randomized trial actually decided to test this concept. And so, about 210 patients with previously untreated advanced non-small cell lung cancer were randomly assigned to get chemo and immune checkpoint inhibitor – either pembrolizumab or sintilimab – and half of them were randomly assigned to get the treatment before 3 PM in the afternoon, and half of them were assigned to get it after 3 PM in the afternoon. And it almost completely recapitulated what was seen in the retrospective cohorts. So, the median progression-free survival in those who got earlier treatment was 13.2 months versus only 6.5 months in those who got it later in the day. So, really enormous difference with a hazard ratio of 0.43, which was statistically significant. And perhaps even more striking, the median overall survival was not reached in the early group versus 17.8 months in the late group with a hazard ratio of 0.43, also highly statistically significant. Even the response rate was 20% higher in the early patients; 75% response rate compared to 56% in the late-time-of-day patients. So very consistent across all measures of efficacy with pretty good matched characteristics across the different groups. And so, I have to tell you, I don't know what to make of this. I certainly was a skeptic about the retrospective series, but now we have a prospective randomized trial that shows essentially the same thing. So, maybe there is a difference between getting treated in the morning, although I have yet to hear someone give a very good mechanistic explanation as to why this would be. What were your thoughts on this? Dr. Vamsi Velcheti: It's indeed fascinating, Nate, and I actually think this was a very interesting abstract. Really, I was caught off guard looking at the data. I mean, if it were a drug, we would be so excited, right? I mean, with those kind of survival benefits. I don't know. I think circadian rhythm probably has something to do with it, like different cytokine profiles at the time of administration. I mean, who knows? But I think it's a randomized trial, and I think I would expect to see a mad rush for treatment appointments early in the morning given this, and at least I want my patients to come in first thing in the morning. It'll be interesting to see. Dr. Nate Pennell: It's important to point out that in this study, everyone got chemo and immunotherapy. And, at least in our cancer center, most patients who are getting platinum-doublet chemotherapy and immunotherapy actually do get treated earlier in the day already, just because of the length of the infusion appointment that's needed. So it really is oftentimes people getting single-agent immunotherapy who are often getting the later, shorter visits. But if you have a choice, I think it would be very reasonable to have people treated earlier in the day. And I do think most of the impressions that I got from people about this is that they would like to see it reproduced but certainly well worth further investigation. And I personally would like to see more investigation into what the rationale would be for this because I still can't quite figure out, yes, if you got it at, say, you know, 5 PM, that's later in the day and I can understand that maybe your immune system is somewhat less receptive at that point than it would be in the morning. But because these checkpoint inhibitors have such long half-lives, it's still in your system the next morning when your immune system is supposedly more receptive. So I don't quite understand why that would be the case. Well, let's move on to the next study. I would like to hear your thoughts on Abstract 8515, “Plasma-Guided, Adaptive First-Line Chemoimmunotherapy for Non-Small Cell Lung Cancer.” Dr. Vamsi Velcheti: Yeah, this was another abstract that seems to be really interesting in my opinion. I think there's kind of a lot of emphasis lately on ctDNA and MRD-based assays to monitor disease. In the lung cancer space, we haven't had a lot of clinical trials looking at this prospectively, and this was one of those pilot studies where they looked at circulating free DNA (cfDNA)-based response-adaptive strategy for frontline patients who are PD-L1 positive. So, patients started with pembrolizumab monotherapy, and based on plasma molecular response after 2 cycles, those patients without response received early treatment intensification with a platinum doublet. So the approach essentially was to reduce the chemotherapy exposure in patients who respond to immunotherapy. And only about 17.5% of the patients on the trial received chemotherapy based on lack of molecular response. So, in this trial, what they found was patients with the cfDNA response had a markedly improved PFS of 16.4 months versus 4.8 months. So essentially, like, this is a really nice study to set a foundation on which we have to do larger studies to incorporate molecular markers trying to look at cfDNA response to inform treatment strategy, either escalation or de-escalation strategies. So, I thought it was a very interesting study. Dr. Nate Pennell: Yeah. I mean, we always have this question for patients, “Should they get immunotherapy alone or combined with chemo?” and I think this certainly is intriguing, suggesting that there may be ways you can monitor people and perhaps rescue those that aren't going to respond to single agent. I'd like to see a randomized trial against, you know, this strategy, perhaps against everyone getting, say, chemoimmunotherapy or make sure that you're not potentially harming people by doing this strategy. But I agree, it's time to move beyond just observing that cell-free DNA is prognostic and important and start using it to actually guide treatment. Dr. Vamsi Velcheti: Yeah, and I would just caution though, like, you know, I think we need more data, but, however, it's certainly a very interesting piece of data to kind of help inform future trials. So, there was another abstract that caught my attention, and I think this would be a very interesting abstract in the EGFR space. Abstract 8506, "Patritumab Deruxtecan (HER3-DXd) in Resistant EGFR-Mutant Advanced Non-Small Cell Lung Cancer Patients After Third-Generation EGFR TKI," it's the HERTHENA-Lung02 study. What do you think about the results of this study? Dr. Nate Pennell: Yeah, this was, I would say, very widely anticipated and ultimately a little disappointing, despite being a positive trial. So, these are patients with EGFR-mutant non-small cell lung cancer who have progressed after a third-generation EGFR TKI like osimertinib. This is really an area of major unmet need. We do have drugs like amivantamab in this space, but still definitely an area where essentially patients move from having a highly effective oral therapy to being in the realm of chemotherapy as their best option. So, this HER3 antibody-drug conjugate, patritumab deruxtecan, had some good single-arm data for this. And we're sort of hoping this would become an available option for patients. This trial was designed against platinum-doublet chemotherapy in this setting and with a primary endpoint of progression-free survival. And it actually was positive for improved progression-free survival compared to chemo with a hazard ratio of 0.77. But when you look at the medians, you can see that the median PFS was only 5.8 versus 5.4 months. It was really a modest difference between the two arms. And on the interim analysis, it appeared that there will not be a difference in overall survival between the two arms. In fact, the hazard ratio at the interim analysis was 0.98 for the two arms. So based on this, unfortunately, the company that developed the HER3-DXd has withdrawn their application to the FDA for approval of the drug, anticipating that they probably wouldn't get past approval without that overall survival endpoint. So, unfortunately, probably not, at least for the near future, going to be a new option for these patients. Dr. Vamsi Velcheti: Yeah, I think this is a space that's clearly an unmet need, and this was a big disappointment, I should say. I think all of us were going into the meeting anticipating some change in the standard of care here. Dr. Nate Pennell: Yeah, I agree. It was something that I was telling patients, honestly, that I was expecting this to be coming, and so now, definitely a bit of a disappointment. But it happens and, hopefully, it will still find perhaps a role or other drugs with a similar target. Certainly an active area. Well, let's leave the EGFR-mutant space and move into small cell. There were a couple of very impactful studies. And one of them was Abstract 8006, “Lurbinectedin Plus Atezolizumab as First-Line Maintenance Treatment in Patients With Extensive-Stage Small Cell Lung Cancer, Primary Results from the Phase III IMforte Trial.” So, what was your impression of this? Dr. Vamsi Velcheti: Yeah, I think this is definitely an interesting study, and small cell, I remember those days when we had barely any studies of small cell at ASCO, and now we have a lot of exciting developments in the small cell space. It's really good to see. The IMforte trial is essentially like a maintenance lurbinectedin trial with atezolizumab maintenance. And the study was a positive trial. The primary endpoint was a PFS, and the study showed improvement in both PFS and OS with the addition of lurbinectedin to atezolizumab maintenance. And definitely, it's a positive trial, met its primary endpoint, but I always am a little skeptical of adding maintenance cytotoxic therapies here in this setting. In my practice, and I'd like to hear your opinion, Nate, most patients with small cell after 4 cycles of a platinum doublet, they're kind of really beaten up. Adding more cytotoxic therapy in the maintenance space is going to be tough, I think, for a lot of patients. But also, most importantly, I think this rapidly evolving landscape for patients with small cell lung cancer with multiple new, exciting agents, actually like some FDA-approved like tarlatamab, also like a lot of these emerging therapeutics like I-DXd and other ADCs in this space. You kind of wonder, is it really optimal strategy to bring on like another cytotoxic agent right after induction chemotherapy, or do you kind of delay that? Or maybe have like a different strategy in terms of maintenance. I know that the tarlatamab maintenance trial is probably going to read out at some point too. I think it's a little challenging. The hazard ratio is also 0.73. As I said, it's a positive trial, but it's just incremental benefit of adding lurbi. And also on the trial, we need to also pay attention to the post-progression second-line treatments, number of patients who received tarlatamab or any other investigational agents.  So I think it's a lot of questions still. I'm not quite sure I'd be able to embrace this completely. I think a vast majority of my patients might not be eligible anyway for cytotoxic chemotherapy maintenance right away, but yeah, it's tough. Dr. Nate Pennell: Yeah. I would call this a single and not a home run. It definitely is real. It was a real overall survival benefit. Certainly not surprising that a maintenance therapy would improve progression-free survival. We've known that for a long time in small cell, but first to really show an overall survival benefit. But I completely agree with you. I mean, many people are not going to want to continue further cytotoxics after 4 cycles of platinum-doublet chemo. So I would say, for those that are young and healthy and fly through chemo without a lot of toxicity, I think certainly something worth mentioning. The problem with small cell, of course, is that so many people get sick so quickly while on that observation period after first-line chemo that they don't make it to second-line treatment. And so, giving everyone maintenance therapy essentially ensures everyone gets that second-line treatment. But they also lose that potentially precious few months where they feel good and normal and are able to be off of treatment. So, I would say this is something where we're really going to have to kind of sit and have that shared decision-making visit with patients and decide what's meaningful to them. Dr. Vamsi Velcheti: Yeah, I agree. The next abstract that was a Late-Breaking Abstract, 8000, “Overall Survival of Neoadjuvant Nivolumab Plus Chemotherapy in Patients With Resectable Non-Small Cell Lung Cancer in CheckMate-816.” This was a highly anticipated read-out of the OS data from 816. What did you make of this abstract? Dr. Nate Pennell: Yeah, I thought this was great. Of course, CheckMate-816 changed practice a number of years ago when it first reported out. So, this was the first of the neoadjuvant or perioperative chemoimmunotherapy studies in resectable non-small cell lung cancer. So, just to review, this was a phase 3 study for patients with what we would now consider stage II or stage IIIA resectable non-small cell lung cancer. And they received three cycles of either chemotherapy or chemotherapy plus nivolumab, and that was it. That was the whole treatment. No adjuvant treatment was given afterwards. They went to resection. And patients who received the chemoimmunotherapy had a much higher pathologic complete response rate and a much better event-free survival. And based on this, this regimen was approved and, I think, at least in the United States, widely adopted.  Now, since the first presentation of CheckMate 816, there have been a number of perioperative studies that have included an adjuvant component of immunotherapy – KEYNOTE-671, the AEGEAN study – and these also have shown improved outcomes. The KEYNOTE study with pembrolizumab also with an overall survival benefit. And I think people forgot a little bit about CheckMate-816. So, this was the 5-year overall survival final analysis. And it did show a statistically and, I think, clinically meaningful difference in overall survival with the 3 cycles of neoadjuvant chemo-nivo compared to chemo with a hazard ratio of 0.72. The 5-year overall survival of 65% in the chemo-IO group versus 55% with the chemo alone. So a meaningful improvement. And interestingly, that hazard ratio of 0.72 is very similar to what was seen in the peri-operative pembro study that included the adjuvant component. So, very much still relevant for people who think that perhaps the value of those neoadjuvant treatments might be really where most of the impact comes from this type of approach. They also gave us an update on those with pathologic complete response, showing really astronomically good outcomes. If you have a pathologic complete response, which was more than a quarter of patients, the long-term survival was just phenomenal. I mean, 95% alive at 5 years if they were in that group and suggesting that in those patients at least, the adjuvant treatment may not be all that important.  So, I think this was an exciting update and still leaves very much the open question about the importance of continuing immunotherapy after surgery after the neoadjuvant component. Dr. Vamsi Velcheti: Yeah, I completely agree, Nate. I think the million-dollar question is: “Is there like a population of patients who don't have complete response but like maybe close to complete response?” So, would you like still consider stopping adjuvant IO? I probably would not be comfortable, but I think sometimes, you know, we all have patients who are like very apprehensive of continuing treatments. So, I think that we really need more studies, especially for those patients who don't achieve a complete CR. I think trying to find strategies for like de-escalation based on MRD or other risk factors. But we need more trials in that space to inform not just de-escalation, but there are some patients who don't respond at all to a neoadjuvant IO. So, there may be an opportunity for escalating adjuvant therapies. So, it is an interesting space to watch out for. Dr. Nate Pennell: No, absolutely. Moving to KRAS-mutant space, so our very common situation in patients with non-small cell lung cancer, we had the results of Abstract 8500, “First-Line Adagrasib With Pembrolizumab in Patients With Advanced or Metastatic KRASG12C-Mutated Non-Small Cell Lung Cancer” from the phase 2 portion of the KRYSTAL-7 study. Why was this an interesting and important study? Dr. Vamsi Velcheti: First of all, there were attempts to kind of combine KRASG12C inhibitors in the past with immune checkpoint inhibitors, notably sotorasib with pembrolizumab. Unfortunately, those trials have led to like a lot of toxicity, with increased especially liver toxicity, which was a major issue. This is a phase 2 study of adagrasib in combination with pembrolizumab, and this is a study in the frontline setting in patients with the G12C-mutant metastatic non-small cell lung cancer. And across all the PD-L1 groups, the ORR was 44%, and the median PFS was 11 months, comparable to the previous data that we have seen with adagrasib in this setting. So it's not like a major improvement in clinical efficacy. However, I think the toxicity profile that we were seeing was slightly better than the previous trials in combination with sotorasib, but you still have a fair amount of transaminitis even in the study. At this point, this is not ready for clinical primetime. I don't think we should be using sotorasib or adagrasib in the frontline or even in the second line in combination with checkpoint inhibitors. Combining these drugs with checkpoint inhibitors in the clinical practice might lead to adverse outcomes. So, we need to wait for more data like newer-generation G12C inhibitors which are also being studied in combination, so we'll have to kind of wait for more data to emerge in this space. Dr. Nate Pennell: I agree, this is not immediately practice changing. This is really an attempt to try to combine targeted treatment with immune checkpoint inhibitor. And I agree with you that, you know, it does appear to be perhaps a little bit better tolerated than some of the prior combinations that have tried in this space. The outcomes overall were not that impressive, although in the PD-L1 greater than 50%, it did have a better response rate perhaps than you would expect with either drug alone. And I do think that the company is focusing on that population for a future randomized trial, which certainly would inform this question better. But in the meantime, I agree with you, there's a lot of newer drugs that are coming along that potentially may be more active and better tolerated. And so, I'd say for now, interesting but we'll wait and see. Dr. Vamsi Velcheti: Yeah, so now moving back again to small cell. So, there was a Late-Breaking Abstract, 8008. This is a study of tarlatamab versus chemotherapy as second-line treatment for small cell lung cancer. They presented the primary analysis of the phase III DeLLphi-304 study. What do you think about this? Dr. Nate Pennell: Yeah, I thought this was really exciting. This was, I would say, perhaps the most important lung study that was presented. Tarlatamab is, of course, the anti-DLL3 bispecific T-cell engager compound, which is already FDA approved based on a prior single-arm phase II study, which showed a very nice response rate as a single agent in previously treated small cell lung cancer and relatively manageable side effects, although somewhat unique to solid tumor docs in the use of these bispecific drugs in things like cytokine release syndrome and ICANS, the neurologic toxicities. So, this trial was important because tarlatamab was approved, but there were also other chemotherapy drugs approved in the previously treated space. And so, this was a head-to-head second-line competition comparison between tarlatamab and either topotecan, lurbinectedin, or amrubicin in previously treated small cell patients with a primary endpoint of overall survival. So, a very well-designed trial. And it did show, I think, a very impressive improvement in overall survival with a median overall survival in the tarlatamab group of 13.6 months compared to 8.3 months with chemotherapy, hazard ratio of 0.6. And progression-free survival was also longer at 4.2 months versus 3.2 months, hazard ratio of 0.72. In addition to showing improvements in cancer-related symptoms that were improved in tarlatamab compared to chemotherapy, there was actually also significantly lower rates of serious treatment-related adverse events with tarlatamab compared to chemotherapy. So, you do still see the cytokine release syndrome, which is seen in most people but is manageable because these patients are admitted to the hospital for the first two cycles, as well as a significant number of patients with neurologic side effects, the so-called ICANS, which also can be treated with steroids. And so, I think based upon the very significant improvement in outcomes, I would expect that this should become our kind of standard second-line treatment since it seems to be much better than chemo. However, tarlatamab is definitely a new drug that a lot of places are not used to using, and I think a lot of cancer centers, especially ones that aren't tied to a hospital, may have questions about how to deal with the CRS. So, I'm curious your thoughts on that. Dr. Vamsi Velcheti: Yeah, thank you, Nate. And I completely agree. I think the data looked really promising, and I've already been using tarlatamab in the second-line space. The durability of response and overall, having used tarlatamab quite a bit - like, I participated in some of the early trials and also used it as standard of care - tarlatamab has unique challenges in terms of like need for hospitalization for monitoring for the first few treatments and make sure, you know, we monitor those patients for CRS and ICANS. But once you get past that initial administration and monitoring of CRS, these patients have a much better quality of life, they're off chemotherapy, and I think it's really about the logistics of actually administering tarlatamab and coordination with the hospital and administration in the outpatient setting. It's definitely challenging, but I think it definitely can be done and should be done given what we are seeing in terms of clinical efficacy here. Dr. Nate Pennell: I agree. I think hospital systems now are just going to have to find a way to be able to get this on formulary and use it because it clearly seems to be more effective and generally better tolerated by patients. So, should move forward, I think. Finally, there's an abstract I wanted to ask you about, Abstract 8001, which is the “Neoadjuvant osimertinib with or without chemotherapy versus chemotherapy alone in resectable epidermal growth factor receptor-mutated non-small cell lung cancer: The NeoADAURA Study”. And this is one that I think was also fairly highly anticipated. So, what are your thoughts? Dr. Vamsi Velcheti: You know, I wasn't probably surprised with the results, and I believe we were all expecting a positive trial, and we certainly were handed a positive trial here. It's a phase III trial of osimertinib and chemotherapy or osimertinib in the neoadjuvant space followed by surgery, followed by osimertinib. It's a global phase 3 trial and very well conducted, and patients with stage II to stage IIIB were enrolled in the study. And in the trial, patients who had a neoadjuvant osimertinib with or without chemotherapy showed a significant improvement in major pathologic response rates over chemotherapy alone. And the EFS was also positive for osimertinib and chemotherapy, osimertinib monotherapy as well compared to chemotherapy alone. So overall, the study met its primary endpoint, and I think it sheds light on how we manage our patients with early-stage lung cancer. I think osimertinib, we know that osimertinib is already FDA approved in the adjuvant space, but what we didn't really know is how was osimertinib going to work in the neoadjuvant space. And there are always situations, especially for stage III patients, where we are on the fence about, are these patients already close to being metastatic? They have, like, almost all these patients have micrometastatic disease, even if they have stage III. As we saw in the LAURA data, when you look at the control arm, it was like a very short PFS. Chemoradiation does nothing for those patients, and I think these patients have systemic mets, either gross or micrometastatic disease at onset. So, it's really important to incorporate osimertinib early in the treatment course. And I think, especially for the locally advanced patients, I think it's even more important to kind of incorporate osimertinib in the neoadjuvant space and get effective local control with surgery and treat them with adjuvant. I'm curious to hear your thoughts, Nate. Dr. Nate Pennell: I am a believer and have long been a believer in targeted adjuvant treatments, and, you know, it has always bothered me somewhat that we're using our far and away most effective systemic therapy; we wait until after they go through all their pre-op treatments, they go through surgery, then they go through chemotherapy, and then finally months later, they get their osimertinib, and it still clearly improves survival in the adjuvant setting. Why not just start the osimertinib as soon as you know that the patient has EGFR-mutant non-small cell lung cancer, and then you can move on to surgery and adjuvant treatment afterwards? And I think what was remarkable about this study is that all of these patients almost - 90% in each arm - went to surgery. So, you weren't harming them with the neoadjuvant treatment. And clearly better major pathologic response, nodal downstaging, event-free survival was better. But I don't know that this trial is ever going to show an overall survival difference between neoadjuvant versus just surgery and adjuvant treatment, given how effective the drug is in the adjuvant setting. Nonetheless, I think the data is compelling enough to consider this, certainly for our N2-positive, stage IIIA patients or a IIIB who might be otherwise surgical candidates. I think based on this, I would certainly consider that. Dr. Vamsi Velcheti: Yeah, and especially for EGFR, like even for stage IIIB patients, in the light of the LAURA study, those patients who do not do too well with chemoradiation. So you're kind of delaying effective systemic therapy, as you said, waiting for the chemoradiation to finish. So I think probably time to revisit how we kind of manage these locally advanced EGFR patients. Dr. Nate Pennell: Yep, I agree. Dr. Vamsi Velcheti: Nate, thank you so much for sharing your fantastic insights today on the ASCO Daily News Podcast. It's been an exciting ASCO again. You know, we've seen a lot of positive trials impacting our care of non-small cell lung cancer and small cell lung cancer patients. Dr. Nate Pennell: Thanks for inviting me, Vamsi. Always a pleasure to discuss these with you. Dr. Vamsi Velcheti: And thanks to our listeners for your time today. You will find links to all of the abstracts discussed today in the transcript of the episode. Finally, if you value the insights that you hear from the ASCO Daily News Podcast, please take a moment to rate, review, subscribe wherever you get your podcast. Disclaimer: The purpose of this podcast is to educate and to inform. This is not a substitute for professional medical care and is not intended for use in the diagnosis or treatment of individual conditions. Guests on this podcast express their own opinions, experience, and conclusions. Guest statements on the podcast do not express the opinions of ASCO. The mention of any product, service, organization, activity, or therapy should not be construed as an ASCO endorsement. More on today's speakers:    Dr. Vamsi Velcheti   @VamsiVelcheti    Dr. Nathan Pennell   @n8pennell   Follow ASCO on social media:     @ASCO on Twitter     ASCO on Facebook     ASCO on LinkedIn   ASCO on BlueSky   Disclosures:   Dr. Vamsi Velcheti:   Honoraria: ITeos Therapeutics   Consulting or Advisory Role: Bristol-Myers Squibb, Merck, Foundation Medicine, AstraZeneca/MedImmune, Novartis, Lilly, EMD Serono, GSK, Amgen, Elevation Oncology, Taiho Oncology, Merus   Research Funding (Inst.): Genentech, Trovagene, Eisai, OncoPlex Diagnostics, Alkermes, NantOmics, Genoptix, Altor BioScience, Merck, Bristol-Myers Squibb, Atreca, Heat Biologics, Leap Therapeutics, RSIP Vision, GlaxoSmithKline   Dr. Nathan Pennell:     Consulting or Advisory Role: AstraZeneca, Lilly, Cota Healthcare, Merck, Bristol-Myers Squibb, Genentech, Amgen, G1 Therapeutics, Pfizer, Boehringer Ingelheim, Viosera, Xencor, Mirati Therapeutics, Janssen Oncology, Sanofi/Regeneron    Research Funding (Inst): Genentech, AstraZeneca, Merck, Loxo, Altor BioScience, Spectrum Pharmaceuticals, Bristol-Myers Squibb, Jounce Therapeutics, Mirati Therapeutics, Heat Biologics, WindMIL, Sanofi 

Jason Howell and Jeff Jarvis break down 1) Anthropic's fair use win in the AI copyright case 2) Pirated book datasets and the looming shadow library trial 3) Apple's rumored talks to acquire or partner with Perplexity 4) What a Perplexity deal could mean for Siri and search 5) Meta's own interest in Perplexity and AI talent wars 6) Google's new Chromebook Plus and on-device AI upgrades 7) Meta's AI-powered smart glasses and the rise of wearables 8) UK study on kids' generative AI habits 9) Chatbots filling therapy gaps for children 10) Sam Altman's take on raising kids with AI 11) OpenAI's IO trademark dispute with Jony Ive 12) Meta's struggle to label AI-generated video 13) Senate's move to block state AI laws 14) Perplexity's Comet browser for Windows 15) John Oliver's takedown of viral AI slop. Subscribe to the YouTube channel! ⁠⁠⁠⁠https://www.youtube.com/@aiinsideshow⁠⁠ Enjoying the AI Inside podcast? Please rate us ⭐⭐⭐⭐⭐ in your podcatcher of choice! Note: Time codes subject to change depending on dynamic ad insertion by the distributor. CHAPTERS: 0:01:03 - Anthropic Scores a Landmark AI Copyright Win—but Will Face Trial Over Piracy Claims 0:25:35 - Bill Gross' ProRata.ai launches its "ethical search engine," gist.ai 0:28:27 - Apple is reportedly considering the acquisition of Perplexity AI 0:35:21 - Meta held talks to buy Thinking Machines, Perplexity, and Safe Superintelligence 0:38:48 - Google brings new Gemini features to Chromebooks, debuts first on-device AI 0:44:41 - Introducing Oakley Meta Glasses, a New Category of Performance AI Glasses 0:53:28 - Turing Institute study on children and AI 0:56:55 - Kids Are in Crisis. Could Chatbot Therapy Help? 1:01:50 - OpenAI CEO says his kids will ‘never be smarter than AI'— and that his parenting style relies on ChatGPT 1:04:09 - OpenAI pulls promotional materials around Jony Ive deal due to court order 1:05:51 - OpenAI's first AI device with Jony Ive won't be a wearable 1:07:10 - Meta told oversight board it can't automatically detect AI-manipulated video or audio. 1:08:13 - Senate Can Keep Ban on State AI Rules in Trump Tax Bill 1:09:51 - Perplexity's AI-powered browser opens up to select Windows users 1:10:50 - John Oliver on AI slop Learn more about your ad choices. Visit megaphone.fm/adchoices

出演者： miko、quim 配信ペース： 隔週水曜日 番組時間：86分35秒 ♯本番組はリモート収録です。 ♯収録時環境の影響により、全体的に聴き取り辛くなっております。 　申し訳ございません。 mikoラジ、第375回です。 海外（米、中）帰りの我さんと、銚子帰りのしがないさん。 それぞれの多忙な日々を、お家ラジオ感覚でざっくりお届け！ SNSにポストしていないことも、あったり無かったりな約80分。 最後までごゆるりとお楽しみくださいませ。 ♯途中で色々とノイズ等入りますが、収録時のものです。 　ご安心ください、お手持ちの機器は正常です。 //////////////////// VOICEVOX:ずんだもん VOICEVOX:四国めたん //////////////////// -------------------- ●お便り募集中！ mikoラジでは以下の内容でお便りを募集中です！ ・ふつおた 　／普通のお便り、お待ちしています！ ・mikoは大変な絵を描いていきました 　／miko画伯に描いて欲しいお題をお待ちしています！ ・メシヲコエテ 　／料理人・mikoに教えて欲しいレシピをお待ちしています！ bit.ly/2GAWjyv 投稿フォームからラジオに投稿が出来ます！ コーナー名を選び、メッセージ・ラジオネーム・お所を入力して、 どんどん送ってください！　お待ちしています！！ ------------ 本ラジオのメインパーソナリティーである「チーム我等(miko/quim)」、 それぞれ以下個人サークルにて活動中です。 ・miko：miko ・quim：SHIGANAI RECORDS（ shiganai.com/ ） 活動詳細については、上記HPの他 各人のブログ/twitter等にて随時告知しておりますので、チェックしてみてください！ ・みころぐ。(mikoのブログ)（ ameblo.jp/miko-nyu/ ） ・@ mikonyu(mikoのtwitter)（ twitter.com/mikonyu ） ・@ quim(quimのtwitter)（ twitter.com/quim ） --- その他の活動については、以下のとおりです！ -- チーム我等がメインクルーとして活動していた「アルバトロシクス（ albatrosicks.com/ ）」、 これまでリリースしたCDは、イオシスショップ（ iosys.booth.pm/ ）にて頒布しております。ご興味ある方は是非！ ---------- ☆2025年6月IOSYSはいてない.comパワープレイ楽曲 01. Stay Foolish 編曲：D.watt 原曲：東方紅魔郷 / おてんば恋娘 収録アルバム：TOHO BOOTLEGS 9 2025・5・5 Release https://www.iosysos.com/discographyportal.php?cdno=IO-0341

Get this full episode and support the pod! ⁠Join our Patreon ⁠for $5 a month for full episodes, bonus eps and exclusive premium content!⁠Join the Discord community⁠Dive into our discord channel to connect with fellow fans, discuss your favorite episodes, and meet the hosts of the show!Apologize for the delay but we've got today's ep filled with lots of bits and lots of laughs! Ollie Hobson and Lauren Summers join us on the pod today to chat'n'prov about palm readings, triple Virgos, ham sub snacks, slip'n'slides and more!FUDGE and Friends with Erin Keif and Jessie Kendall is going down tonight at iO at 8 pm. If you plan on coming, PLZ use code FUDGEFRIEND to get your discount online!Follow Ollie on socials for info on upcoming shows and music!Follow Lauren for updates on where to see her performing around town!Performers:Hosts:⁠ ⁠Damian Anaya⁠⁠,⁠ ⁠Tim Lyons⁠⁠, and⁠ ⁠Dan White⁠⁠

Ce mardi 24 juin, Frédéric Simottel a reçu Yves Maitre, operating partner chez Jolt Capital et ancien président de HTC, Clément David, président de Theodo Cloud, et Lucas Perraudin, fondateur de AI Partners et ancien directeur de Meta Reality Labs. Ils se sont penchés sur l'appareil mystérieux d'OpenAI et de "io" de Jony Ive, et l'intention de Mark Zuckerberg de relancer sa stratégie d'IA, dans l'émission Tech & Co, la quotidienne, sur BFM Business. Retrouvez l'émission du lundi au jeudi et réécoutez-la en podcast.

In this episode, we welcome Alan Taylor. Alan is an Emmy-winning Director who has worked on shows including “The Sopranos,” “Six Feet Under,” “Sex in the City,” “The West Wing,” “Mad Men,” “Deadwood,” “Game of Thrones” and “House of the Dragon”. He's also directed films such as The Many Saints of Newark, Thor: The Dark World, and Terminator: Genisys. In our chat, he shares about his early days, cinematic inspirations, experiences on epic shows such as “The Sopranos,” working with James Gandolfini — plus many insights into his creative process and workflow.“The Making Of” is presented by AJA:Commercial shoots require speed and precision, which is why Dubai-based freelance editor Nikolay Ivanov depends on AJA's Io 4K Plus for fast, reliable I/O for on set editorial. Find out how he uses the technology alongside other creative tools to collaborate with stakeholders and deliver cuts while the camera is still rolling. Read the Story HereVimeo L.A. Event:Tuesday, June 24 | VidiotsA night of inspiring Vimeo Staff Picks + live filmmaker commentary!Join the Vimeo curation team as they screen recent Staff Picked films with live, unscripted commentary from some of the best creators on Vimeo.6:30pm Doors7:30-9pm Films + commentary 9-11pm Reception - complimentary drinks + bites!RSVP required. Screening and reception are free to attend!Register hereThunderbolt 5 Speed. Ultra Portable Storage.The OWC Envoy Pro Ultra the first portable SSD to harness the power of Thunderbolt 5, delivering real-world speeds over 6000MB/s in a rugged, pocket-sized design. With up to 4TB of capacity and next-gen bandwidth, it's built for high-res video, VFX, and demanding post-production workflows—anytime, anywhere. Lightweight, bus-powered, and blazing fast, it redefines what portable storage can do.Explore it hereNew Solutions from Videoguys:Now through June 30, 2025, get more value when you buy an Atomos monitor-recorder from Videoguys.com! Purchase a Ninja or Ninja Ultra and receive a FREE qualified 240GB SSD. Upgrade to a Shogun Classic, Shogun Ultra, or Sumo 19SE and get a FREE qualified 480GB SSD. To claim your free drive, simply buy from Videoguys.com and complete the mail-in rebate directly through Atomos.With five big reasons to go Atomos—record direct from the sensor, enable a direct-to-edit workflow, capture longer sessions, access pro monitoring tools, and share your shoot—this is the perfect time to upgrade. Act fast, this offer ends June 30, 2025! Call Videoguys at 800-323-2325 to find the right Atomos monitor-recorder for your workflow.Browse hereCheck out the ZEISS Otus ML:Now on sale, the Otus ML 1.4/50mm photography lens from ZEISS is the new generation of high-quality optics for your photographic art. Find it at your favorite photo retailer! Explore it herePodcast Rewind:June 2025 - Ep. 87…“The Making Of” is created by Michael Valinsky.Promote your products or services to over 200,000 filmmakers, TV production pros, and content creators reading this newsletter… contact us at mvalinsky@me.com Get full access to The Making Of at themakingof.substack.com/subscribe

durée : 00:27:38 - Les Midis de Culture - par : Marie Labory - Au programme aujourd'hui, une émission spéciale littérature ! Les critiques partagent leurs coups de cœurs littéraires, avec deux livres parus récemment, et deux plus anciens, à mettre dans vos valises cet été. - réalisation : Laurence Malonda - invités : Marie Sorbier Productrice du "Point Culture" sur France Culture, et rédactrice en chef de I/O; Johan Faerber Editeur, essayiste, critique littéraire.

En este episodio Treki nos habla del unico SO que mereció la pena en la WWDC, concretamente de iPadOS y una gran noticia relacionada con Stage Manager, ademas de la eterna pregunta que se le hace a Apple sobre la unificación de MacOS y iPadOS y que una vez mas el gran Graigh ha respondido con un interesante ejemplo. Finalmente habla de Jony Ive y OpenAI y su IO (o su no IO)

Stai imparando l'italiano e vuoi che il tuo modo di parlare sembri davvero naturale? Allora devi assolutamente evitare quegli errori comuni che tradiscono immediatamente uno straniero. In questo articolo scoprirai i 10 errori più frequenti (+1 bonus) che impediscono a molti stranieri di parlare come dei veri italiani. Una volta che avrai imparato a riconoscerli ed evitarli, il tuo italiano apparirà molto più fluente e autentico! 10 Errori da Evitare per Suonare come i Madrelingua A proposito di errori, in questo articolo ne troverai 10 da evitare per non far arrabbiare una mamma italiana. 1. L'Uso Scorretto di "Bello" e "Quello" Prima dei Sostantivi Uno degli errori più comuni riguarda l'uso di "bello" e "quello" davanti ai sostantivi. Molti studenti dicono erroneamente: ❌ SBAGLIATO: Belli amici Quelli libri ✅ CORRETTO: Begli amici Quei libri La regola fondamentale: "bello" e "quello" usati prima di un sostantivo o un aggettivo funzionano esattamente come gli articoli determinativi. Quindi diremo: Bell'amico (come "l'amico") Begli amici (come "gli amici") Quel libro (come "il libro") Quei libri (come "i libri") Quell'albero (come "l'albero") Quegli alberi (come "gli alberi") Ricorda: "belli" e "quelli" non vanno MAI usati prima di un sostantivo! Sono forme che si usano solo quando l'aggettivo è separato dal nome. 2. Milioni e Miliardi: Una Sola "L" e la Preposizione "Di" Un errore molto comune riguarda la scrittura di "milioni" e "miliardi". Attenzione: in italiano hanno una sola "L"! ✅ CORRETTO: Un milione di euro Un miliardo di persone Regola importante: Dopo "milione" o "miliardo" non dimenticare mai la preposizione "DI"! Eccezioni da ricordare: Se dopo "milione" (o "miliardo") c'è un'altra quantità, non si usa più la preposizione: "Un milione e 520mila persone" La preposizione "DI" ritorna con "e mezzo": "Un milione e mezzo di persone", "Un milione e mezzo di euro" 3. Verbi che Richiedono l'Ausiliare "Essere" Molti studenti pensano che solo i verbi di movimento o i verbi di cambiamento di stato richiedano l'ausiliare "essere" nei tempi composti. Ma attenzione! Ci sono altri verbi importanti che utilizzano "essere": Piacere: "Quel libro non mi è piaciuto per niente" Costare: "Questa casa è costata molto" / "Questo viaggio è costato molto" Durare: "Il film è durato troppo" Mancare: "Voi mi siete mancati" Questi verbi sono spesso dimenticati dagli studenti stranieri, ma sono fondamentali per parlare correttamente l'italiano! 4. Ripetizione: Imperfetto vs Passato Prossimo Molti studenti si confondono quando devono esprimere una ripetizione nel passato. La domanda è: quando usare l'imperfetto e quando il passato prossimo? La regola è semplice ma cruciale: IMPERFETTO = ripetizione non determinata nel numero PASSATO PROSSIMO = ripetizione con un numero determinato Esempi pratici: "Da bambina mangiavo spesso i biscotti" (non sappiamo quante volte) "Da bambina ho mangiato 10 volte i biscotti" (numero preciso) "Ve l'ho ripetuto mille volte!" (numero determinato, anche se esagerato) 5. Andare vs Venire: La Differenza che Fa la Differenza Uno degli errori più difficili da correggere riguarda l'uso di "andare" e "venire". La differenza è fondamentale per suonare naturali: ANDARE = indica allontanamento rispetto a chi parla (o chi ascolta) VENIRE = indica avvicinamento verso chi parla (o chi ascolta) Esempi chiarificatori: "Tu vai a Parigi" (io non sono a Parigi) "Tu vieni a Parigi" (io sono a Parigi) "Io vado a Parigi" (chi ascolta non è a Parigi) "Io vengo a Parigi" (chi ascolta è a Parigi) Caso speciale importante: VENIRE si usa anche quando chi parla e chi ascolta si muovono INSIEME verso la stessa destinazione, anche se nessuno dei due è lì. Esempio: "Stasera vado al cinema." "Vengo anche io!" (con te,

Ben sits down with two of the authors of a new NCITE report on malign case studies of AI: NCITE Senior Scientist Sam Hunter, Ph.D., and I-O psychology doctoral student Alexis D'Amato. They discuss malign use of specialized, unconstrained LLM's, AI-generated music, autonomous weapons systems (AWS), and more. Follow this link to read the full list of case studies: "Examining the Malign Use of AI: A Case Study Report" by Emma Theobald, Alexis d'Amato et al. For more NCITE research on AI, check out the below articles:  Examining Similarity-Attraction Principle and Intergroup Conflict on Malevolent Creativity Ideation Harnessing Harm: Artificial Intelligence's Role in the Amplification of Malevolent Creativity and Innovation

Crash DMs for Beth, Ellie, Io, Jen, & Milly. The consignment shop is having a fire sale! No, not THAT kind of fire… Follow this series on… ▶RSS: https://aaronbsmith.com/cogwheel/tag/cause-and-effect/feed/ ▶Patreon: https://www.patreon.com/cogwheelgaming ▶Mastodon: https://is.aaronbsmith.com/@cogwheel MP3 Download: Cause & Effect Ep 58: Intermission Music Used: “Pandora's Box (FB Mix)” by christofori is licensed as Public Domain and … Continue reading "Cause & Effect Ep 58: Intermission"

Meet the talented Rich Sohn! After being introduced to improv in college, he moved to Chicago in 1987, so he's definitely a seasoned pro in the Improv world. He studied, taught and directed at the Annoyance Theatre, IO and, Second City. As a teacher, he was at The Annoyance Theatre where Rich primarily found his voice and approach. His teaching style is highly influenced by Mick Napier. He moved to LA in 2017 and now teaches at The Pack Theater. He has directed, written and performed hours and hours of comedy content. Designed curriculum to help professionals and students find and perfect their voice. And improvisation has remained at the root of everything he does. We talked about what he looks for in his students and his teaching style. I think you'll admire Rich as much as I do!

Oggi con Matteo e Raffaele facciamo un po' il giro, non tanto dell'Italia, ma delle notizie. Una di queste potrebbe far arrabbiare molto gli studenti al rientro dalla pausa estiva. Trascrizione interattiva e Vocab Helper Support Easy Italian and get interactive transcripts, live vocabulary and bonus content: easyitalian.fm/membership Come scaricare la trascrizione Apri l'episodio in Transcript Player (https://play.easyitalian.fm/episodes/e7e34c2tz24rx7674cub0) Scarica come HTML (https://www.dropbox.com/scl/fi/e7e34c2tz24rx7674cub0/easyitalianpodcast174_transcript.html?rlkey=jnedhmeocmf9bbhxddar19bjd&st=0vyu2d0o&dl=1) Scarica come PDF (https://www.dropbox.com/scl/fi/ygd5waux20l48e42woccj/easyitalianpodcast174_transcript.pdf?rlkey=m54d4pn3d9ev81m4n74rj78da&st=ct3uqpdi&dl=1) Vocabolario Scarica come text file (https://www.dropbox.com/scl/fi/o2eys39fwx9et526k44dp/easyitalianpodcast174_vocab.txt?rlkey=2af4qp3h4n3o5sosqhbhh6j1m&st=is741sm7&dl=1) Scarica come text file with semicolons (https://www.dropbox.com/scl/fi/brz1xeg8ro058kitfbw3p/easyitalianpodcast174_vocab-semicolon.txt?rlkey=215zpcfpiz8u0areqtxphqu51&st=1jwdqp5g&dl=1) (per app che utilizzano flashcard) Iscriviti usando il tuo feed RSS privatoper vedere la trascrizione e il vocab helper subito sulla tua applicazione per ascoltare i podcast sul tuo cellulare. Note dell'episodio What Italians Really Think About Their Politics - https://www.youtube.com/watch?v=BT7IvwSEUHE&t=7s Oggi si inizia dai banchi di scuola. Ma attenzione! Vietati i cellulari! Cosa ne pensate? Matteo e Raffaele ne parlano, e cercano di capire come funzionera'. Ma abbiamo proprio bisogno di avere sempre con noi il cellulare, e soprattutto, serve agli studenti? Il turista anonimo continua a colpire. Questa volta si sono seduti su una sedia. Quindi? Poveri turisti non possono nemmeno riposarsi un attimo tra un monumento ed un altro? Beh certo, possono riposarsi, ma non su una sedia di... Finiamo tutti a mare! Quest'anno le coste italiane sono apparentemente molto pulite, e c'e' una regione che ha vinto per essere la regione con il mare piu' pulito! Curiosi? Vi possiamo dare un indizio: Confina con Campania e Calabria. Indovinato? Trascrizione Raffaele: [0:23] Buongiorno Matteo. Matteo: [0:25] Buongiorno, come va? Raffaele: [0:28] Settimana scorsa avevo il fiatone perché avevo fatto le scale a piedi, attività fisica. Questa settimana ho il fiatone stando fermo. Matteo: [0:39] No, è arrivato il caldo. Raffaele: [0:42] 31 gradi, sopra il 60 per cento di umidità: si suda da fermi, si soffre maledettamente. Matteo: [0:54] Mannaggia. Speriamo che questa cosa non continui. Raffaele: [0:57] Sei andato via giusto in tempo. Il problema che mi pongo io, Matteo, è che se a giugno, a metà giugno, fa così caldo e si soffre così tanto, cosa succede a luglio e agosto? Cioè dove andiamo a finire? Matteo: [1:16] E dove andiamo a finire? Raffaele: [1:18] E pensa che ci sta ancora chi è sui banchi di scuola a studiare con questo caldo. Matteo: [1:29] La vita in Italia in questo momento è calda. Raffaele: [1:32] È molto molto calda. Tu, Matteo, ricordi quando hai fatto l'esame di maturità? La data. Matteo: [1:41] Era giugno, le prime due settimane di giugno. Raffaele: [1:45] Grosso modo di questi tempi. (Sì sì.) Io invece ebbi la sfortuna... il mio cognome inizia con la T, quando si selezionò la lettera per decidere da dove iniziare per fare gli esami orali, giustamente uscì proprio la A. Estratta a sorte la A, e quindi io ero l'ultimo di tutta la classe a fare l'esame. L'ho fatto, se non ricordo male, il 4 luglio. E sono andato a fare l'esame di maturità, non so se te l'ho mai raccontato, col costumino. Cioè il costume e sopra il pantalone: finito l'esame, la prova orale dell'esame di maturità, siamo andati direttamente al mare a festeggiare. Ma si può studiare con questo caldo? Si può stare sui libri a scuola con questo caldo? Matteo: [2:35] No, sicuramente no. Fortunatamente tutte le scuole, a parte gli esami, sono chiuse e riapriranno a settembre. Raffaele: [2:47] Sì, generalmente chiudono intorno al 10 giugno, ma già molto prima ci sono tanti studenti che, finite le interrogazioni, finiti i test, i compiti in classe, come si chiamano, lasciano la scuola generalmente verso la fine di maggio. E ha senso proprio per questo discorso del caldo, considera che non siamo neanche ancora in estate ma già fa così caldo. Quando rientreranno a scuola gli studenti, probabilmente troveranno una novità. Bello o brutta? Non lo so, bisogna chiederlo a loro. Matteo: [3:26] Ah, e che novità troveranno? Poveri studenti, poveri studenti. Raffaele: [3:31] Poveri. A partire da settembre 2025 il cellulare in classe sarà vietato anche agli studenti delle scuole superiori. Matteo: [3:42] E questa è una cosa interessante, è un approccio molto... non dittatoriale, mi sembra un po'... dittatoriale mi sembra troppo, però non me lo aspettavo. Raffaele: [3:55] È un approccio forte, no? È stato fatto l'esperimento con le scuole inferiori, chiamiamole così, quindi le scuole elementari, le scuole medie, e poi adesso si è deciso di espandere questo divieto alle scuole superiori. Alle scuole elementari è stato facilissimo: forse nessun bambino alle scuole elementari ha il cellulare. Anzi mi correggo: io conosco tanti bambini che hanno il cellulare in quarta o quinta elementare ma non lo portano proprio a scuola. Alle medie già comincia ad essere complicato perché un po' tutti hanno il cellulare. Al liceo, alle scuole superiori sarà complicato far rispettare questo divieto. Matteo: [4:44] È una cosa interessante anche perché sto cercando di pensare, cercando di empatizzare il più possibile con i ragazzi e i genitori, per quanto posso ovviamente, e non trovo un motivo per andare contro questa decisione: è giusto che tu non puoi usare il cellulare in classe. Raffaele: [5:12] Eh, siamo sempre nel discorso del libero arbitrio, no? In teoria gli studenti dovrebbero capire che non è il caso di utilizzare il cellulare durante la lezione. Spieghiamo un attimo bene come funziona a partire da settembre: praticamente all'ingresso in classe ci sarà una cassettina oppure si utilizzerà semplicemente il cassetto della cattedra dell'insegnante. E ogni studente che entra in classe, oppure quando entra il professore, i ragazzi devono consegnare il cellulare, mettere il cellulare in questa cassettina o nel cassetto, in modalità non disturbare, di modo che vibrazioni e suonerie non diano fastidio. E recuperare il cellulare in teoria alla fine della giornata ma in pratica quando il professore uscirà di classe, i ragazzi andranno a controllarsi le notifiche, salvo poi rimettere il cellulare a posto quando entra il professore dell'ora successiva. Ha senso così? Cioè alla fine è solo un togliere il cellulare agli alunni durante la lezione? Matteo: [6:27] Allora la questione è che abbiamo a che fare con ragazzi giovani che per una questione anche fisica hanno dei seri problemi a comportarsi in maniera logica. Perché si stanno ancora sviluppando e quindi hanno bisogno di avere a che fare con delle regole e con dei divieti, secondo me. Cioè non puoi basarti sempre e solo sulla logicità, e il ragionamento che dovrebbero fare gli studenti, che sono giovani. Raffaele: [7:14] Eh lo so, ma dirgli proprio "lasciate il cellulare qua, spegnete il cellulare, consegnatelo"... Potresti anche dire "spegnetelo però tenetelo voi, ci fidiamo." Perché poi alla fine è quello un po' il discorso. Tu dici: " Non mi fido." Matteo: [7:28] No, il discorso è proprio quello, il discorso è: si può arrivare a quello dopo una... è un po' come nelle disintossicazioni forti, tu mi insegni... No anche tu, se tu vuoi prendere meno caffè, sei arrivato in una situazione in cui ne stai prendendo tanto, non è che inizi a prenderne di meno. Vai un po' drastico i primi periodi. Raffaele: [7:55] Eh non lo so, non lo so, ci sono diversi approcci, per questo non è così semplice la questione, perché tu dici: il cellulare in classe è un male, quindi la soluzione è togliamo il cellulare. Matteo: [8:11] Ma in realtà il cellulare in classe è un male. Raffaele: [8:14] Dipende da cosa ci fai. Matteo: [8:16] Ma in questo momento lasciando stare il "vorrei che fosse", però se eliminiamo il "come vorrei che fosse la classe ideale oggi", il cellulare e l'uso del cellulare in classe distrae solamente. Raffaele: [8:40] Allora voglio chiarire un po' la mia posizione: io fondamentalmente sono d'accordo con te, nel senso che sono d'accordo che dire ad un tredicenne "tieni il cellulare acceso sul banco durante la lezione" è un invito a nozze per lui. E invece di sentirsi il professore di storia e filosofia, aprirà TikTok e si guarderà i video silenziosamente facendo finta di seguire. Quindi diciamo che è un modo per togliere questa distrazione. Idealmente non sarebbe necessario. Idealmente la lezione dovrebbe essere coinvolgente, e ti dirò di più, dovrebbe trovare un modo per coinvolgere i ragazzi attivamente. E perché non coinvolgere anche con l'uso del cellulare? Cioè per me la scuola dovrebbe andare verso una digitalizzazione massiccia, forte, soprattutto in Italia dove invece su questo siamo un po' indietro. Non ci sono abbastanza computer per tutti gli allievi, non ci sono i tablet per tutti e consentire l'utilizzo del cellulare, in maniera coordinata con l'insegnante eh, attenzione... può essere invece un modo per sopperire a questa mancanza. Idealmente, eh... Matteo: [10:03] Sono d'accordo con te. Idealmente. Ma poi basta che... ricordo le mie lezioni di informatica, e non so se tu hai mai fatto lezioni in aula computer in cui c'erano questi grandi computer, dietro i quali... erano così grandi che ti potevi nascondere dietro il monitor. E lo studente, il suo primo obiettivo quando... non il suo primo obiettivo nel senso che si sveglia e pensa che vuole fare questo.... Ma il cervello ha costanti, dà costanti impulsi per distrarti, sempre. E al primo momento noi, anche senza cellulari, perché entrambi abbiamo fatto i nostri studi durante un periodo in cui non c'era proprio il cellulare... Raffaele: [10:58] Usciva, ti dico la verità, si mandavano gli sms. Matteo: [11:01] Sì, vabbè, però, insomma, era così, non... oltretutto era vietato, non potevi metterti col cellulare sul banco. Raffaele: [11:15] Però mi ricordo che già all'ultimo anno di liceo noi avevamo quasi tutti il cellulare e ci mandavamo i messaggini, quindi già si presentava il problema. Non potevi, chiaro che non potevi, però nessuno ti sequestrava nulla. Matteo: [11:28] Eh no, però la questione è che adesso non solo puoi mandare messaggini ma per esempio puoi compromettere un compito in classe, certo probabilmente ci saranno delle metodologie per i quali se c'è il compito in classe il cellulare viene tolto o comunque viene spento o non lo so. Però già la maggior parte degli studenti è ignorante... Ma buttiamoli proprio i cellulari... Cioè secondo me il cellulare genericamente dovrebbe essere iniziato ad usare a 20 anni, perché crea una serie di problemi. A meno che non si inizi a scuola a fare educazione digitale, che può essere anche fatta con carta e penna, però ti iniziano ad educare a come usare i social, come comportarsi, cosa fare, cosa non fare, cosa evitare. Raffaele: [12:31] E qui convergiamo, Matteo: hai detto una cosa bellissima, esattamente quello che proporrei di fare io, perché il problema secondo me non è la distrazione del cellulare sul banco. Certo le elimini, non hai più la distrazione. Ma non educhi a gestire il cellulare, e secondo me il problema di tanti ragazzi di oggi è proprio quello. Pensa che la proposta successiva di questo governo è: niente social media sotto i 15 anni. E di questo poi ne riparliamo magari in un'altra puntata. Però è per dire che secondo me anche questo divieto non è per non far distrarre gli studenti, è per evitare che magari anche gli episodi di bullismo in classe vengano ripresi con i cellulari, poi questi video girino nelle chat, sui social media e creino problemi poi giganteschi. Il problema è proprio quello. Il problema è cosa ci fanno i ragazzi col cellulare. E quindi dovrebbero essere educati all'utilizzo consapevole del cellulare. Secondo me a partire dalla scuola, quindi non sequestrando i cellulari, ma insegnando come usare i cellulari in maniera utile e non fare danni con i cellulari. E poi chiaramente c'è l'altra faccia della medaglia, ovvero una volta usciti da scuola non è che "cellulare libero per tutti, tutta la giornata". Perché attualmente è così, no? La scuola dice "vi vieto il cellulare a scuola, a casa decideranno i genitori, fate quello che volete." Il problema è poi che in questa altra metà della giornata, anche i genitori, anche la famiglia deve continuare con questa educazione all'utilizzo della tecnologia. Matteo: [14:19] Sì sì sì sì, purtroppo l'educazione è un grande problema. Raffaele: [14:33] Dove eravamo rimasti? Ma inteso settimana scorsa? A Roma con i turisti che si rubavano le statue e le basi delle colonne: è successo di nuovo? Non dirmi che è successo di nuovo... Matteo: [14:49] È successo, più o meno. Niente monopattini, niente basi di colonne, ma a quanto pare dei turisti hanno fatto un guaio. Raffaele: [14:59] Un guaio bello grosso e bello caro, molto caro. Parliamo ancora di comportamenti sbagliati nei musei. Questa volta siamo a Verona, un museo che si chiama Palazzo Maffei, che ospita delle opere d'arte. In particolare un'opera d'arte di un artista contemporaneo italiano che si chiama Nicola Bolla, che ha riprodotto una sedia ispirata a uno dei quadri più famosi di Van Gogh. E l'ha riprodotta totalmente fatta di cristallo e Swarovski, quindi uno degli oggetti più fragili per definizione. Raffaele: [15:48] Ebbene, durante una visita a questo museo, una coppia quasi anziana, adesso non sappiamo molti dati, vediamo soltanto le immagini dei video di sorveglianza. Questa coppia di signori anziani, aspetta l'uscita della guardia poi si avvicina furtivamente alla sedia, che si chiama proprio "la sedia di Van Gogh". Fin lì tutto bene, puoi avvicinarti, puoi fare le tue foto. Solo che a un certo punto lui si china e si siede, si appoggia sull'opera d'arte. Adesso, secondo te: è fatta di cristallo, come può andare a finire? (Malissimo. In frantumi.) Esatto. La sedia si è immediatamente spaccata. E, tu dirai: i due mortificati avranno informato la guardia che stava poco distante in qualche altra sala. "Guardate, è successo questo, non volevo, l'ho urtata e si è rotta." Invece i furbastri sono scappati via, hanno fatto finta di nulla, hanno lasciato il museo e si sono dileguati. Le guardie del museo si sono accorte del danno troppo tardi, perché sono uscite dal museo per provare a rintracciare i colpevoli ma non li hanno potuti trovare. E quindi il museo ha fatto una denuncia contro ignoti, si dice in questo caso: è una cosa che è possibile fare quando non sai chi ha fatto il danno, il furto, fai una denuncia contro ignoti. E i carabinieri in questo caso si sono attivati, hanno preso la situazione molto seriamente, dal video sono riconoscibili in volto i due, si vede per bene l'abbigliamento, gli oggetti che portano con sé. E quindi per adesso non l'hanno trovati, ma chissà che non li troveranno a breve. Matteo: [17:55] Beh, ci sono spera... speriamo, ma non tanto per una questione di, come dire: "Voglio punirli". Però non vorrei che iniziasse questo nuovo sport di "fa il danno e poi scappa". Raffaele: [18:15] Sì, no, non va bene. Il danno, tra l'altro, la sedia vale tra i 15.000 e i 50.000 euro, quindi non parliamo di milioni di euro, però comunque è un danno non da poco. E hanno contattato l'artista: fortunatamente l'artista, dopo aver constatato i danni ha detto "ok, sì, la possiamo sistemare." Tra l'altro l'artista è stato intervistato dai giornali e l'ha presa sul filosofico, diciamo così. Ha detto "No, non ci sono rimasto male anzi ci ho visto qualcosa di ironico e positivo, mi è sembrata quasi una performance di arte moderna". Matteo: [19:00] Vabbè certo, è stata registrata, l'ha vista forse. Raffaele: [19:04] Eh, si sarà fatto una risata e ha detto "Mi ha dato persino lo spunto per la prossima opera da realizzare". Matteo: [19:11] Ah, incredibile. Raffaele: [19:13] "Sedia spezzata con turista immortalato accovacciato", chissà. Secondo me questo è il calore. Troppo caldo sta dando alla testa. Hai un antidoto per tutto questo caldo? Matteo: [19:26] Eh certo: andate a mare! Raffaele: [19:35] Eh vabbè ma il mare in Italia... Cioè l'Italia è tutta mare, è una penisola, c'è talmente tanto di quel mare che non sai dove andare. Dove andare a mare? Matteo: [19:48] Possiamo chiederlo ai mitici della bandiera blu. Raffaele: [19:55] La bandiera blu è uno degli strumenti che si utilizza in Italia per identificare le condizioni del mare delle spiagge italiane. Dare una bandiera blu ad una spiaggia vuol dire che lì l'acqua è pulita e bella, è l'idea di massima. Quest'anno in Italia, nel 2025, abbiamo 246 bandiere blu, quindi abbiamo almeno 246 posti da scegliere per avere l'acqua eccellente e addirittura recentemente c'è stato uno studio dei laboratori delle agenzie ambientali che hanno fatto una statistica e hanno visto che la regione con l'acqua più pulita, inteso meno inquinata in tutta Italia, è la Puglia. Il 99,7% delle acque è eccellente, ha una qualità eccellente, quindi l'acqua meno inquinata, praticamente 99,7% vuol dire che è perfetta. (Non male.) Più nello specifico, Matteo, tra l'altro le bandiere blu confermano questo trend e anche il maggior numero di bandiere blu in tutta Italia ce l'hanno Liguria, Puglia e Calabria, quindi si conferma la Puglia tra le migliori destinazioni. Tu sei stato in Puglia, sei stato al mare, ricordi qualche spiaggia, ti va di consigliarmi quella che secondo te è la spiaggia più bella d'Italia o la spiaggia più bella in cui sei stato in Italia? Matteo: [21:40] Allora, io sono stato in Puglia sì. Sono stato nel Gargano. Quindi la parte vicino al tallone dello stivale. E poi sono stato al confine con la Puglia, nel Molise, più verso nord. Siamo andati ogni tanto, siamo sconfinati in Puglia, spiagge un po' più sabbiose. Non sono andato ma dicono che un posto meraviglioso sono le isole Tremiti. Raffaele: [22:18] Eh sì. Matteo: [22:20] Che sono di fronte la Puglia e il Molise. Raffaele: [22:23] Esatto, sono un po' bistrattate, vuol dire maltrattate, spesso dimenticate quando si parla di isole italiane perché pensano tutti quanti alle isole della Sicilia. Mentre invece le Tremiti in Puglia sono una destinazione turistica bella, bella, bella. Matteo: [22:45] Sì. Raffaele: [22:46] Io sono stato in Puglia, non sono stato a mare in Puglia, perché sono stato in inverno, anche nei luoghi insomma che poi d'estate sono belli affollati. Però non ho avuto la possibilità di godere della spiaggia quando sono stato in Puglia. Quindi la mia selezione varia un po' tra Lazio e Campania soprattutto. Ed in particolare ti voglio raccomandare in Campania Marina d'Ascea, anche qui Bandiera Blu, una bella spiaggia ampia, mare molto pulito. Ma non solo, ce ne sono tante. C'è Palinuro. C'è un posto adesso non mi ricordo neanche più come... insomma, in quale zona specificamente si trova. Quando eravamo più ragazzini con la famiglia andavamo in un posto che si chiama "lo scoglio della tartaruga". E si trova a Vico Equense, in provincia di Napoli, non troppo lontano da Sorrento. Ed era un posto fantastico perché tu arrivavi, poi dovevi prendere la barchetta e la barchetta ti portava in questa spiaggia. Si chiama scoglio della tartaruga perché ci sono dei sassi poco distante dalla spiaggia che hanno proprio la forma di una tartaruga. E c'era l'abitudine, adesso non penso sia più consentito, di arrampicarsi su questa tartaruga e tuffarsi dalla testa o dal guscio della tartaruga. Non ci sei mai stato? Non ne hai mai sentito parlare? Matteo: [24:27] No, ricordo vagamente. A Vico Equense ci sono stato spesso quando ero piccolo e tutta quella parte lì è fantastica, ci sono delle spiagge e dei panorami e dei profumi bellissimi. Pino, mi ricordo sempre questo profumo di pino, l'albero e il mare che assieme creano un... Guarda, mi sento a mare adesso solo a pensarci. Raffaele: [25:01] Eh, ma io... infatti questo è un esercizio psicologico. Se penso alla spiaggia e al mare, automaticamente mi rinfresco. Nel Lazio ti consiglio una spiaggia che si chiama Serapo. Tecnicamente la zona, la cittadina a cui appartiene si chiama Gaeta, quindi siamo tra Napoli e Roma, non troppo lontano da Terracina che menziono sempre. Ed è insomma una bella bella spiaggia. Occhio al traffico, non facilissima da raggiungere, bisogna parcheggiare, poi fare delle scalinate... però insomma merita. Secondo alcuni la spiaggia più bella in Italia invece è la spiaggia dei conigli a Lampedusa. Matteo: [25:46] Non ci sono mai stato, è molto famosa tant'è vero che ne ho sentito già parlare. Raffaele: [25:52] Eh sì, effettivamente guardare le foto... sembra di guardare i Caraibi o addirittura le Maldive o la Polinesia. Matteo: [26:02] Ce ne sono tantissime che ricordo in Sardegna. Raffaele: [26:06] Esatto, volevo dire questo. Cioè che ognuno può avere la sua preferita, io non sono mai stato in Sardegna, però secondo tanti le spiagge più belle in Italia sono proprio in Sardegna. Secondo posto forse per la Sicilia e poi Puglia ed altre. Però grosso modo l'idea collettiva è questa: le spiagge più belle in Italia sono in Sardegna. Sei mai stato a mare in Sardegna? Matteo: [26:36] Sì, sono stato a mare in Sardegna per un paio d'anni da giovane, liceale, sono andato con gli amici, ed è stato, penso, il mare più bello che abbia mai visto in vita mia: bellissimo. Limpidissimo. Raffaele: [26:59] Facciamo così: me ne parli un poco nel nostro after show, ci spostiamo di là e approfondiamo questo argomento, e anche qua parliamo di qualche altra cosa. Matteo: [27:12] È vero perché ho fatto qualcosa. Raffaele: [27:15] Cosa hai fatto? Matteo: [27:16] Mistero? Raffaele: [27:17] Mistero: se volete sapere cosa ha combinato Matteo dovete seguirci nel nostro after show. Ricordate che è uno dei nostri bonus per i sostenitori, i membri della nostra comunità. Quindi non perdete tempo, cliccate sul link nelle show notes, diventate sostenitori di Easy Italian, riceverete l'after show, la trascrizione integrale interattiva della puntata, la traduzione multilingue, ed il Vocab Helper che mostra a schermo fino a 10 tra le parole più importanti o più difficili minuto per minuto. E che vuoi di più dalla vita? Matteo: [27:55] Una spiaggia e del mare. Raffaele: [27:59] Io stavo per dire un Lucano... Matteo: [28:01] Ciao. Ciao.

“You don't have to transition your entire business. You just need to start. Small beginnings are okay.”  Revolutionizing Water Treatment Through Smart Tech  In this episode of Scaling UP! H2O, host Trace Blackmore welcomes Kevin Kuhne, Founder and President of Energy Resource Products, LLC, for a deep-dive conversation on the emerging role of smart technology and artificial intelligence in water treatment.  With decades of experience leading tech-driven innovation, Kevin unpacks how intelligent systems, edge computing, and real-time data processing are reshaping operations in the field—from cooling towers to complex distribution networks.  Whether you're managing plant performance or driving strategic growth, this episode offers a credible look into the future of industrial water management.   From Controllers to Edge-Based Intelligence  Kevin introduces the evolution of traditional controllers into what he calls “computers at the edge.” These intelligent systems collect real-time data, deliver predictive alerts, and can execute secure firmware updates—all without requiring field visits. This shift eliminates the dependency on gateways and streamlines site management through centralized dashboards, saving time and resources.  He illustrates how these systems not only detect pump failures before they occur but also reduce chemical overdosing incidents by offering immediate visibility into feeder issues and sensor discrepancies.   Breaking the Barrier: Selling Smart Tech to Stakeholders  One of the recurring challenges in adopting new technology is overcoming skepticism—especially from IT teams and procurement stakeholders. Kevin outlines strategies for simplifying the sales conversation: focus on specific ROI outcomes like labor savings, chemical usage reduction, and improved equipment uptime. He also breaks down how modern security protocols and machine-to-machine communication are easing concerns around connectivity and data protection.   AI and the Cloud: Turning Data into Action  The discussion advances into how AI-enabled platforms now process disparate data streams in the cloud to support smarter decision-making. Rather than waiting for weekly reports, professionals can now access dynamic dashboards and build customized data visualizations to proactively manage client sites from any location.  Kevin emphasizes that this shift empowers service professionals, not replaces them. By removing manual data bottlenecks, smart tech allows for more impactful engagement and long-term client retention.  Future-Proofing the Industry  Kevin predicts a near future where IO configurations fade, sensors become brand-agnostic, and user interfaces resemble common mobile apps. He encourages water professionals to begin small—pilot smart technology in a single location, gather feedback, and use those wins to accelerate broader adoption.  He closes with a message for early-career professionals: embracing smart technology from the start will enable them to deliver higher value and grow their impact in the industry.   Conclusion  As industries move toward intelligent infrastructure, water professionals must adapt. This episode provides a grounded, expert-led perspective on how to practically and securely implement these technologies. For technical managers, engineers, and company leaders, this is a timely and strategic conversation you won't want to miss.  Stay engaged, keep learning, and continue scaling up your knowledge!    Timestamps    01:38 – Trace Blackmore shares a reflection on sharks and ecosystem sustainability, tying into the episode's broader theme of technology and responsible action.   10:06 – Water You Know with James McDonald  11:30 – Upcoming Events for Water Treatment Professionals   14:08 – Interview with Founder, President, and Coach Kevin Kuhne of Energy Resource Products  16:11 - Kevin defines smart tech, contrasting traditional controllers with edge-based computing that delivers real-time data, predictive analysis, and remote access  33:10 — Future technology trends 36:12 — Message for newcomers: Kevin encourages young professionals to embrace tech as a tool for empowerment, not a threat    Quotes  “Your customer is already integrating AI in other parts of their business. If we're not doing it, someone else will.”   “Security is the real roadblock, but if the equipment has a computer-type base of operation, IT is far more comfortable.”  “Smart tech is identifying those areas that we can enhance information, translate it, and then act on it.”    Connect with Kevin Kuhne  Phone: 17632263945  Email: kevin@energyresourceproducts.com   Website: www.energyresourceproducts.com    LinkedIn: www.linkedin.com/in/kevin-kuhne-1812626   Click HERE to Download Episode's Discussion Guide    Guest Resources Mentioned   12 Rules for Life: An Antidote to Chaos: Jordan B. Peterson   The Problem of Pain by C.S. Lewis  A Christmas Carol (Collins Classics) by Charles Dickens    Scaling UP! H2O Resources Mentioned  AWT (Association of Water Technologies)  Scaling UP! H2O Academy video courses  Submit a Show Idea  The Rising Tide Mastermind  AWT Technical Training (Coming Soon - 2026)   422 Inside the Association of Water Technologies with John Caloritis    Water You Know with James McDonald   Question: What is the breakpoint chlorination ratio of chlorine to ammonia required to reach a true free chlorine residual?    2025 Events for Water Professionals  Check out our Scaling UP! H2O Events Calendar where we've listed every event Water Treaters should be aware of by clicking HERE.   

Donald Macleod investigates the life of a Renaissance genius, Giovanni da PalestrinaGiovanni Pierluigi da Palestrina (c.1525-1594) was one of the most influential composers in European classical music. With his countless masses, motets and madrigals, infused with a deep sense of spirituality and musical beauty, Palestrina was named the 'Saviour of Church Music' at a revolutionary time when Rome was rewriting the rules of music composition. But what do we know about this mysterious character, between historical fact and hagiographic myth? Donald Macleod follows the clues, to try and reconstruct the story of a fascinating composer, on the (approximately) 500th anniversary of his birth.Music Featured: Sicut cervus Laudate pueri Pueri hebraeorum (arr for dobro) Puer qui natus est Missa Assumpta est Maria (excerpt) Josquin des Prez: O virgo prudentissima Josquin des Prez: Fortuna d'un gran tempo Costanzo Festa: Sancta Maria succurre miseris Sacred Madrigals, Book 2, Città di Dio Ricercar del primo tuono Magnificat Primi toni Missa Ecce sacerdos magnus (Sanctus) Quam pulchri sunt gressus tui Pulchra es, amica mea (arr Volbers for recorder ensemble) Missa Papae Marcelli (excerpt) Vergine bella… Vergine saggia… Vestiva i colli Sabbato Sancto: Lectio III, Incipit oratio Ieremiae prophetae Motecta festorum totius anni cum Communi Sanctorum – liber primus Misso Herodes Nicola Vicentino: Jerusalem convertere Cristóbal de Morales: Gaude et laetare, Ferrariensis civitas Motecta festorum totius anni cum Communi Sanctorum (Fuit homo missus a Deo) Missa Papae Marcelli (Sanctus) Ricercar del secondo tuono Missa sine nomine a 6 arr Johann Sebastian Bach L'homme armé (exceprt) Adoramus te Christe arr Leopold Stokowski for orchestra O admirabile commercium Missa Ut re mi fa sol la (excerpt) Io son ferito (instrumental version) Missa Brevis (excerpt) Canite tuba (arr for brass ensemble) Deh hor foss'io col vago della luna (on a text by Petrarch) Offertoria totius anni (Jubilate Deo) arr A. Frackenpohl for brass ensemble Stabat Mater Missa pro defunctis (Sanctus-Benedictus) First Book of Madrigals (Sestina. Mai fu piu crud'o spietata morte) Ad te levavi Johann Joseph Fux: Gradus ad Parnassum (Fugue) Francesco Soriano: Alpha à 6 Canticum Canticorum (Osculetur me osculo oris sui) Missa Memor esto verbi tui a 5 (Credo) Missa Cantantibus organis (from the motet Cantantibus Organis by Palestrina) Sacred Madrigals, Book 2 (E questo spirto) Libera me Domine Ave MariaPresented by Donald Macleod Produced by Julien Rosa for BBC Audio Wales & WestFor full track listings, including artist and recording details, and to listen to the pieces featured in full (for 30 days after broadcast) head to the series page for Giovanni Pierluigi da Palestrina (c.1525-1594) https://www.bbc.co.uk/programmes/m002d7cq And you can delve into the A-Z of all the composers we've featured on Composer of the Week here: http://www.bbc.co.uk/programmes/articles/3cjHdZlXwL7W41XGB77X3S0/composers-a-to-z

ぬるぽ放送局投稿フォーム https://docs.google.com/forms/d/e/1FAIpQLScwYSAEyRhDCHd-JRk9dLA05JKnGINgvnDhY3Xmkw2lwwDjQw/viewform 2025年6月パワープレイ 01. Stay Foolish 編曲：D.watt 原曲：東方紅魔郷 / おてんば恋娘 収録アルバム：TOHO BOOTLEGS 9 2025・5・5 Release https://www.iosysos.com/discographyportal.php?cdno=IO-0341 番組時間：98分10秒 出演者：夕野ヨシミ、たくや VOICEVOX:ずんだもん VOICEVOX:四国めたん ---- 2025/6/19に公開録音したものを配信いたします。 ラジオ記事はリスナーのEEチャンピオンさんが書いてくれているので楽してます。 ＜オープニング＞ ・21時きっかりに始まりました ・2回に1回は2の倍数 ・北海道なのにエアコン付けてますよ ・即売会におけるイオシスの列のよう ・よそのサークルの列整理してますし ・シャッター前配置って昭和の話してます？ ・列整理の同人誌 ・名華祭はイベントスタッフが多い ・お弁当がいいのかな？ ・ラフな格好した刺青入りガードマン ・彫物だけにね ＜Aパート＞ ・ふつおたです ・元同僚の結婚式で横浜へ ・初老のイベントやってますよ ・0時から酒飲んで仕上げて行く ・結婚式は寝てても大丈夫 ・エンジニア寝をしてる夕野ヨシミ氏 ・ラーメン博物館って何があるんですか？ ・ラーメンの化石 ・アンパンマン博物館は何があるんですか？ ・そんな、まじめなことをネイキッドロフトでやられてもな ・渋谷のはかせの部屋 ・俳優を見ると犯人が分かるドラマ ・はかせがアニメの話をしないときは儲かってる ・前川が落ちてた ・陰謀論流行ってるんだ ・歩き始めためかとき ・3年B組ー！唯我独尊ー！ ・ブラウザ三国志のスマホアプリ版 ・steam版ブラウザ三国志のMOD ・クラスはバッター ・元祖二刀流 宮本武蔵 ・つまぽんがプロ野球にハマってる ・サンキューピッチおすすめです ・2000万円のリースとは ・炎上商法なのか？ ・名華祭の話 ・感想はよかったです（語彙力） ・C＆Cさんは、ちゃんとやってましたよ ・まろんくんはサークル反復横跳びが出来る ・アクスタの現物をどこかに置きたい ・スカ警アクスタはいいぞ ・老舗のアクリルサークルになっちゃった ・石川のねこ ・あのswitch2は当たったやつだから ・今週は芸能界とスポーツ界がプチ炎上なんだな、なるほど ・って毎週やん ・赤い三角コーン ・プリキュアのシャア ・来週は実写かな？ ・ぬるぽ聞いてます（ｺｯｿﾘ） ・5％アップするのに押すの？ ・懲役も禁固もなくなりました ・半分がリピーター ・大人のキッザニアだ ・老人福祉施設になってる ・ぬるぽは幅広く何でもウエルカムです ＜Bパート＞ ・アレンジがちゃんと令和最新版 ・デジタルリリースも始まってるのでお聞きください ・これはどこで聞けるんですか？ ・東方アレンジもいろんなところで聞けるってすごいな ・CD焼いてたあの頃 ・出すのは簡単だけど聞いてもらうのは大変 ・CDにちゃんとシール貼るのも大変 ・やることないから仕事してるんだ ・みつをたです ・6月の気温じゃねー！ ・嘘だと言ってよみつを ・新装版発売おめでとう ・しかも免税かい ・働く車は高いよ ・母親29歳にビックリ ・レベルEいいぞ ・飛影はそんなこと言わない ・知らないところでお見合いが組まれてる ・11年前に結婚してる ・ダブルインパクトは年寄りの大会に ・梅雨前線に喝！出ちゃった ・子供がいると子供の話始めちゃう ・親子で すってはっくん ・全部隠語だったのか ・こいつらヒメウズラしたんだ！ ・ED曲にBEYOND THE TIMEはズルじゃん ・親戚じゃない小室さん ・頬を赤らめるハロ ・みんながおめでとう ・ホロライブswitch2当選早抜けレース ・じゃあ、エンディングに行きましょう ＜エンディング＞ ・イオパの中継はなくなりましたので現地で聞いてください ・Aiobahn +81 feat. ななひら & P丸様。- 天天天国地獄国 (Official Music Video) 　作詞：夕野ヨシミ(IOSYS) 　YouTube1000万再生めでたい！ ・作詞しましたｲｴｰｲ ・何がとは言わないんだけど、最近話題のTシャツがありますよ 　2025イオシス万博公式ロゴマークTシャツ ・楽曲提供のお知らせ 　〖 Original 〗 ぴゅぴゅっと☆エロイムエッサイム / なぃとめあ 〖 IOSYS (D.watt&まろん) 〗 　作詞：まろん(IOSYS) 　作編曲：D.watt(IOSYS) ・ランプ（意味深） ・作詞提供のお知らせ 　【主題歌 解禁PV】『ネコぱら セカイコネクト』（ネココネ）スマホ/PC向け新作　　ゲーム Aiobahn書き下ろし新曲『Cute Domination』 　作詞：john=hive（IOSYS） 　作編曲：Aiobahn +81 　歌唱：水無月時雨（CV. M・A・O） ・デジタルリリースのお知らせ 　TOHO BOOTLEGS 9 　リッスンナウしてねー ・IO-0335 IOSYS ALL TIME TOHO BEST COLLECTION 　IOSYSの在庫が完売しました！ 　追加のCDプレス予定はありません～ ・提供楽曲のMVが公開されました！ 　『ぬこぬこ♡なでにゃん♡ETERNAL♡』 　作詞：恋汐りんご・七条レタス(IOSYS) 　作編曲：D.watt(IOSYS) ・6/21-22　北海道ご当地キャラフェスタ ・中々発表にならないものたくさんありまーす ・7/3の生放送は2本録りの予定です ・イオシスショップも20周年 ・土曜日はブルアカの生放送あります（出演はありません） ・うなぎ食べてがんばろう

With websites covering topics like entertainment (ScreenRant), gaming (Polygon) and automotive (CarBuzz), Valnet caters to users across a wide array of interests.But according to Ji Heon Kim, Valnet's head of monetization, Valnet realized it could create more value for its users by encouraging them to subscribe or authenticate themselves.Maybe a “mass scale” of users wouldn't sign up for their websites, but perhaps 10% would. And, as Kim puts it, that “10% would still be valuable, and we can do a lot with that 10%.”“We created more value to [those] users, more exclusive content and high-quality content,” Kim says. “All of that became an initiative on the content side for us to deliver a premium model and give users an incentive to sign up.”Kim further talked with The Current Podcast about balancing advertiser value, user experience and performance, which he says are “always affecting each other.” Episode TranscriptPlease note, this transcript  may contain minor inconsistencies compared to the episode audio.Damian Fowler (00:00):I'm Damian Fowler, and welcome to The Current Podcast. Today we're talking to one of the biggest digital publishers. You might not know by name, but you've definitely read their stuff. I'm talking about Net. The company behind Screen Rant, the Gamer, Kaleida make use of, and a bunch of other sites that rack up hundreds of millions of sessions every month. Joining me today is Ji Kim Valnet's, head of monetization. Ji'S been leading the charge on everything from supply path optimization to first party data to figuring out how to drive real revenue without compromising the reader experience. We'll get into some of the big shifts they've made in their tech stack and how they're bringing newly acquired brands like Polygon into their ecosystem and what other publishers can learn from their approach.Ji Kim (00:52):At Valnet, I'd like to think of us as a publishing powerhouse. We started very small. Our motto is humble and hungry. We like to remind ourselves that it's always good to keep a humble mindset. I've been at NET for 10 years and we've grown tremendously. We've went through a lot ups and downs, but even as we grow, we like to think that we're small and agile and the publications we range from automotive, gaming, technology, entertainment, but entertainment has always been our flagship, but we've been kind of branching outside of that and trying to expand more and more. And then we have some lifestyle brands as well as sports.Damian Fowler (01:35):Let's talk about a moment that changed the game for Net. Can you walk us through your, I guess we're going to talk about supply path optimization at first anyway, which is a hot topic around these parts and what work you did around supply path optimization, like cutting resellers and boosting direct inventory. Could you talk us through that a little?Ji Kim (01:57):It's an ongoing process. It's certainly, I think most people agree that SPO is not an easy thing to achieve. You can commit to it one shot, but that's much harder to do considering that there will be a revenue impact. So for us, we tried both ways. We took a few sites and we took the direct approach and we saw a pretty decent stability, and then some other sites did not, and then we have to kind of revert back to it. SPO, it was always a topic that was talked about but not well enforced. And tradedesk took a big initiative to push publishers towards it. And then we started working closely with Jounce Media as well, with Chris Kane started kind of talking through some of the ideas, how should we go about it? How do we retain the value and still achieve removing the resale alliance and keep our inventory as clean as possible?(02:51):But initially our outlook of SPO was about making our inventory as clean and transparent as possible. Net considers ourselves as a premium publisher and we want to make sure that the advertisers see that as well. So we were heading in that direction. But ultimately, I think the biggest challenge with SPO was it's impossible to do an AB test because you have one A TXT file and you can't test one setup with the resell alliance, one setup without. So that's been pretty challenging to understand where's the value going, where is it coming from? And even with the Resell Alliance, when you talk to the SSPs with Resell Alliance, they'll go, oh, these are PP deals. These are not just rebroadcasting and all this stuff. So trying to understand the granularity and all that details of what each resale align means was very difficult. But ultimately we know we have to go in that direction, but we know it's not going to happen overnight, so we're kind of just taking a step at a time.Damian Fowler (03:51):That's great. What would you say was the kind of catalyst or moment that sparked that shift?Ji Kim (03:57):We always talked about advertiser value. It is important to yield as much value as possible and get the performance that we need. We always think that advertiser value is important, and when we think about that, it's like you go through stages. You go, okay, viewability needs to be important. Let's get viewability up to above standard, above average, make sure our CTR is good, but it's high quality clicks. It's not just users just clicking on stuff. Then you go through the lines and eventually you get to SPOs. Make sure that advertisers know what inventory they're getting access to, what they're buying, and make sure that they're getting insights. The transparency is there. Then we've increased the value of our inventory.Damian Fowler (04:46):Yeah, I mean that's the key, right, obviously. And speaking of that, having made these changes, are you in a position to be able to see the kind of impact that they've had from a revenueJi Kim (04:58):Perspective? Honestly, I don't think I can everything, especially with these kinds of stuff, what I've learned is it doesn't change overnight. Let's say we remove all the reseller lines yesterday. Today, likely the performance is going to drop initially and maybe things recover over time, but there's so many moving parts that it's hard to associate the value towards SPO, and that's a lot of things that we do in this industry. But I think that's when we like to look at it as, you know what? Ultimately we are improving the quality of our inventory, so we will get rewarded at some point. And that's how you move forward. But with SPO, I think the other side is that it's not just about removing reseller lines. You also have to market yourself and tell the advertisers that, Hey, we have gone in this direction. We have removed the reseller lines. All of our inventory is direct. It's clean. And that part is also hard to do. We haven't spent a lot of time or resources into marketing ourselves, and that's why we talked about, people may not know net, but they know our brands. It's the same thing. It's like we are now making a big push to let people know who Val net is, and that's going to go in hand in hand with this stuff.Damian Fowler (06:21):In terms of that messaging around the surgery as it were you're doing on the supply path, does that land well with advertisers?Ji Kim (06:32):I think it's always positively looked at when you tell them, it's like everybody, it is never negative, but I don't know if actually if it's meaningful for them because at scale, they're buying at scale. So yeah, we're a big publisher, but they're also buying at multiple publishers. Maybe only small portion of their budgets come to us. So it's positive, but I don't know if it's all that meaningful to them. At least that's what I've felt.Damian Fowler (07:04):So in addition to the SPO, what other tweaks or changes are you as head of monetization looking at to basically bring in those ad dollars and keep readers satisfied, I suppose?Ji Kim (07:17):Yeah, so there's three things. So we looked at the advertiser value, but then there's the user experience and then the performance side. So always those three things, there's constantly affecting each other. Ad density is probably one of the biggest part of advertiser value and performance and user experience. So we are constantly trying to reduce our density, and we look at this metric impressions per session and request per session. So we look at that and injections our injections based on content length, a paragraph breaks and all that stuff. So we'll try to work with the content team to create optimal breaks. I'll have a little sit down session with the content team. The leads say, okay, this is how the admin injection works, and how you break out your content really does impact, because we won't break a paragraph in half to inject an ad. So there needs to be natural breaks for the ads to inject. So if you have massive paragraphs, we're going to have less ad injections, which is fine if the content works like that, but they also need to think about how all this stuff works.Damian Fowler (08:26):That's really interesting. I mean, I think that sweet spot between not being the Vegas strip, but also ads have to populate at the right time to have value.Ji Kim (08:35):For net, we've focused mostly on open market programmatic spend. We have a small direct initiative. This is something that we've been trying to grow, but when you don't have huge direct sales initiative and direct spend coming in, you kind of need the density because the CPMs that you get from open market is much lower. So we want to try to move away from that as much as possible. I don't think found that will ever be a publisher where we drive like 50% of the revenue from direct sales, but we want to grow it to maybe 15, 20%. And once we do that, we can yield higher CPMs, which allows us to reduce the density, which would be better for advertiser value, better for user experience, and we'll still get the performance that we need to kind of go forward.Damian Fowler (09:24):So it's a balance.Ji Kim (09:25):Yeah. Yeah. I think if we can drive higher CPMs, we would love to reduce density, but it's always the constant battle between the two of, okay, well we reduced density. Oh, we went too far. Okay, we got to bring it back a little bit.Damian Fowler (09:38):How difficult is it to kind of innovate in ad tech? This is a broader question, I guess given how fast things are changing, especially on the programmatic front,Ji Kim (09:47):It's been very, very difficult. Rapidly changing environment is definitely one of them, and you have to adapt quickly. For example, the video definition of having instream outstream, and then now there's a third definition of accompanying that stuff. When it happened, the enforcement happened quickly, so we had to adapt quickly, and that's difficult. But innovating is, I think, much more difficult than just adapting to the new policies and new rules. So many different ways to innovate pre, for example, you have the open source code, you build that, but there's so many customizations that you can do and even a single customization, you interpret how you should approach that topic and how you should build your tech. So you kind of have to talk to your developers and walk through. And our biggest challenge I would say was bridging the gap between developers and ad ops. I was like, because I am an ad ops guy, I understand programmatic landscape very well, but our developers do not. And I'm not a developer, I'm not a technical guy. Obviously through 10 years I've learned a lot of stuff, but still, if I needed to build something, I'm not going to be able to tell them exactly how to build it. So you need somebody in the middle that understands both sides,(11:03):And that was the most difficult part. And eventually we did find resources that they were able to bridge that gap and were able to build stuff. But ultimately, there's just so many different ways to build your product and you want to make sure that product that you build or tech stack that you build is going to keep that balance that you need between the user experience, the performance, and the density, everything that pertains to page speed as well. If you build it to be too slow, everything gets affected as well, and that's harder to tell. So yeah.Damian Fowler (11:37):So how have some of these technical changes influenced your broad and monetization philosophy?Ji Kim (11:43):Yeah, so I guess one of the things, if we talk about authentication, we talk about cookie deprecation and why authentication became so important to majority of the publishers. And I remember our thought process around authentication was pretty pessimistic, I would say. But eventually we said know what? We can create content or value for the users that's going to want them to sign up and want them to get authenticated. And we said we got to start somewhere. Ultimately, maybe we've become a little bit more realistic about what critical mass of a value would be if we're at, if we're expecting 50% of users will log in, that's not going to happen, but 10% is still very meaningful. So it was about our philosophy was changing, about our expectations changing and still understanding that 10% could be very valuable and we can do a lot with that 10%. So we created more value to the users are more exclusive content, high quality content, high quality videos. All of that stuff became an initiative on the content side for us to deliver the premium model and to give users the incentive to authenticate a sign up on.Damian Fowler (13:03):That's really interesting. I think one of the things that also I'm hearing is that you kind of have different audiences, but you're getting to understand your audiences. I mean, this strategy gives you more insight into who's coming.Ji Kim (13:15):Yeah. We also created what we call threads. They can talk about the article, talk about topics that we're discussing, and that really improved our engagement.Damian Fowler (13:30):As you look to the future, how do you think about, as it were, locking in some of these changes and this value that you see from this audience?Ji Kim (13:40):So I want to go back a little bit about innovating and how difficult it is. So I went through the stages of, okay, what am I focusing on to optimize to yield more value? And initially it was demand. Okay, we want to work with as many high quality as P as possible, but then you do work with all of them. There are going to be going to be one or two that come here and there, but generally speaking, they're not going to create incremental value. They'll just take a piece of pie that was taken by somebody else, not meaningful value. Then you work on ad tech innovation, all that stuff, and that we'll continuously work on that, but that also has lots of limitations, and you eventually reach a plateau point of say, you're not going to find a lot low hanging fruits. So now we come to premium inventory, which we need to learn our users, we need to learn who they are so we can offer these users to our advertisers to grow our PMP programmatic direct, as well as your conventional IO based direct deals that's going to yield as higher CPMs.Damian Fowler (14:53):Yeah, I mean, talk of premium inventories is characteristic of the moment we are in when it comes to programmatic sales for publishers.Ji Kim (15:02):Yeah.Damian Fowler (15:04):Let's draw back and look at the big picture and some of the kind of industry context. I guess think I'm correct in saying Valnet reach has more than 400 million sessions a month across its network. That's correct. And how do you think about that, that kind of scale when every property has its own audience profile and publishing rhythm?Ji Kim (15:30):Yeah, it's sometimes a bit overwhelming how much reach our sites have, but I always try to look at it as our advantage, and this is the opportunity that hasn't been tapped into, is that okay, we're 95% of our inventory is sold in the open market, and we have so much data that we could collect and leverage in order to drive higher value. And it's just looking at it, it's overwhelming, but you start to see the real value that hasn't been tapped into, and that's exciting, but it's also very, very difficult to manage all that information, manage that data, and use it properly. So yeah, I mean it excites me, but also I know how challenging it can be to create value through that. So we're taking one step at a time, even first party data collection. I wouldn't say we're crazy sophisticated, but we're keeping it a level that we know how to manage and understanding it well first and then starting to kind of grow a step-by-step.Damian Fowler (16:45):Yeah, I mean, I suppose the whole back and forth about third party cookies may have provided a spark. I know it lit a fire under the industry. Speaking of first party data, so that is a focus for you?Ji Kim (16:56):Yes, yes. But I believe when it was really a huge focus for the industry was when Google had first announced that they're going to deprecate third party cookies, and we had the initial moment of, oh, you know what? We also need to look into this, but we didn't want to panic. Our outlook was, I'm sure everybody went through the initial panic. We did too, but we didn't want to stay in that moment. And we said, okay, what's realistically going to happen for publishers like us? How much first party data can we collect and really sell because we don't have a huge direct sales initiative? And at that point we had none. And you can't grow direct sales overnight. It's a highly competitive environment, and you're entering that new market. You have to build relationships, you have to have crazy amount of salespeople that are constantly going out there representing balance inventory.(17:55):And we weren't set up for that, and we weren't willing to just fully invest everything into growing that at the time. So we said, well, maybe first party data isn't as important. Collecting first part data isn't as important as just understanding how to go about direct sales. So that's what we worked on. We've hired salespeople, we enter that space. I was very naive about how direct sales worked, and now we have a better understanding. We have good salespeople that understand our values as well. We don't want to just go out and sell anything and everything. We want to understand the creative types that we're also selling isn't going to impact user experience horribly and negatively. The high impact guys, the site scans when they're done, right, it's great user experience, but it could also go the other way. So we wanted to build a baseline first, and that's what we did the last few years. And now we can go after the first party data in a more sustainable way for us.Damian Fowler (18:56):Let's talk about your acquisition of Polygon from Vox Media. Speaking of inventory that expands the real estate, how does that property fit into what you're doing?Ji Kim (19:07):So Polygon, obviously, we go through a lot of due diligences. We look at different opportunities, and Polygon was an easy one to go through because we knew Polygon has great content, it has a great foundation of creating high quality content. But the difference was that Fox has a lot of direct sales. I can't remember the exact number, but it could have been 75%, 80% of their revenue was generated, direct sold inventory, and then 20% was open market. And for us, it would've been the other way around, flipped around even less. Maybe 95% open market, 5% directive. Initially when we acquired it would've been a hundred percent open market, but that's also why it excite us because it's a premium inventory that doesn't get seen in the open market. Open market buyers don't see the bid requests coming from that website as much. So we're super happy, but we knew this was a high quality inventory, high quality website, and we knew that there was a very small chance that it was going to go poorly.Damian Fowler (20:20):Interesting. When you buy a property like that, you're actually buying an audience to a certain extent.Ji Kim (20:25):Yeah, absolutely.Damian Fowler (20:27):Do you think about audiences as discreet to the publications or do you see crossover?Ji Kim (20:34):Crossover? Yeah, lots of crossover.Damian Fowler (20:37):Yeah. Alright. So I guess the big question here is for other publishers looking to upgrade this strategy that we're talking about, especially in this very complex environment, which is something you clearly understand very deeply, what's one piece of advice that you might offer?Ji Kim (20:54):I think you have to think about realistically what you should go after, what opportunities you should go after. So many things that come up right now, I think the big thing is curated media. And on our end, a lot of the SSPs and DSPs are doing the work for us. They going out and curating our inventory for us, and that's fine. But if you were to go after that and trying to grow it, but you don't really have the resources, it's easy to just kind of see everybody, what everyone else is doing, like, oh, I want a piece of that too, but it's not going to yield the value. Same value if you don't have the right resources in place if you're not focused on that opportunity. So my advice would be to understand which opportunities realistically are you able to get and have the right resources who are going to be passionate about that. Take accountability. That's huge, the accountability part. And that's not something you can just kind of force people. You have to believe that this person that's taking on this project can be really passionate and sink their teeth into it. If you got that, then go after those things. But it's too hard to go after every single opportunity there is. Even if seemingly it seems like a low hanging fruit. Nothing is really that simple in this industry.Damian Fowler (22:15):That's for sure. So finally, we're going to wrap this up with some what we call hot seat questions. So what's one thing you're obsessed with figuring out right now?Ji Kim (22:27):How to yield more value? No, no, no. I'll give a better answer than that right now. For me, it's how to grow direct sales sustainably and scale it in a way that we don't get too bloated. Because through acquisitions, one of the most valuable things that I get is insight. I get to see under the hood of a lot of publishers, small to medium to large, how they operate, what is their strategy and direct sales. I've learned some of the big publishers do it extremely well. It's a well-oiled machine, it's not bloated. They generate a ton of revenue, but some have a huge cost, and that's what we were afraid of. And right now it's very hard to do. So you need the right sales team, you need the right operational guys, you need account representation, you need reporting guide and all this stuff. And right now I am trying to find a way to scale it, but without having massive costs, just kind of take over and then expect this to yield value in the next year or two. I want that line to kind of grow together. And that's not an easy thing to do, obviously. And I'm looking for the right resources. I'm looking to build relationships with agencies with limited guys, just hustle through it and offer them our inventory, charm them, whatever it may take. But yeah, that's what I'm currently obsessed.Damian Fowler (24:01):Okay. What's still missing in the ad tech stack that you wish someone would build?Ji Kim (24:07):I don't know if this would fall under their ad tech stack, but I think we could really benefit from a bit more standardization around, it could be reporting and creatives. Maybe I'm speaking out of line because I'm on the inventory side, so I don't know everything that goes on the buy side and the creative side. But what I see is that there's so many different creatives that just either break the page, the creative's broken, it's too heavy, it slows down the page, and it's hard to target those and remove those. It can come through so many different channels. So if there is a bit more standardization around what kind of creatives are acceptable, I'm sure there is some or a standard already, but it needs to be honed in a bit more maybe.Damian Fowler (25:00):What's one thing advertisers misunderstand about monetizing Publish it inventory today?Ji Kim (25:08):So I thought about this and something that it's more of my frustration around advertisers perspective. I understand it, but a bit more frustration because it's hard to create context around it, which is brand safety. I understand the brand side. I advertise side on why they wouldn't want to associate their brand with certain content, but brand safety is police by keyword list and it's very restrictive. And some of the,Damian Fowler (25:37):It's one toolJi Kim (25:38):And it's like, okay, and we have gaming sites that will, a lot of gaming, natural will talk about shooting, but some of the game developers won't want to associate with those articles. And it's like, hang on, hang on. Now you bet you guys also have games that are first person shooter or whatnot. You don't want to associate with those type of articles. There's a bit of a mismatch, and I think it's just hard to manage that. So they go with a broader approach and I get it, but I think it's just there needs to be more about understanding the context of certain articles. And it's like the word shooting can be anything, everything. Right?Damian Fowler (26:22):Yeah, I like that. I've been hearing more about a shift from brand safety to brand suitability, which brings in the concept of context. What's something unexpected you've learned from reader data or behavior recently?Ji Kim (26:39):So I wouldn't say it's recent, but it's something that's surprises me how the smallest change that I, from my perspective is like, is that really going to do anything? But at our scale, the numbers changed so drastically. Recently we were playing around with the video size because our outstream unit will float once the user are scrolling and the size of that unit. Obviously we want to give advertiser value, so we want to make it as big as possible. But then user experience wise, it could be very bothersome because as they're trying to read, there's a video playing. So we want to keep mindful of that. And we're constantly testing the size of that unit and we decreased by 10% and 10%. While it's significant, if you look at the actual size of the unit to the naked eye, you really wouldn't be able to tell what the difference is. But the CTR of that video unit changed drastically. It was cut in half, actually. And that's the thing is like, okay, users are really sensitive to these things. And to me it's not, maybe I'm looking at it too often, but that's always, that boggles my mind and it always catches me by surprise when I see the numbers is like, wow, I did not expect that. I did not expect users to behave this way.Damian Fowler (28:00):That's amazing. The details really matter.Ji Kim (28:02):Yeah, Big time. Damian Fowler (28:03):And that's it for this edition of The Current Podcast. We'll be back next week. The Current Podcast is produced by Molten Hart. A theme is by Love and Caliber, and our associate producer is Sydney Cairns. And remember,Ji Kim (28:21):I like to think of us as a publishing powerhouse. We started very small. Our motto is humble and hungry. We like to remind ourselves that it's always good to keep a humble mindset.Damian Fowler (28:34):I'm Damian, and we'll see you next time.

Ecco i 3 principi e le 3 aree che analizzeremo nel workshop di Lunedì 23 alle 20:45, io ti aspetto, iscriviti qui: https://store.psicologo-milano.it/webinar-genitorialita-23-giugnoIn questo episodio ti spiego perché, secondo me, la genitorialità è il percorso di crescita personale più potente e importante che possa mai esistere.Ecco perché ho deciso di mettere insieme le mie competenze professionali e personali per creare la masterclass di lunedì, per svelarti i segreti per diventare un genitore 3.0.Ecco le 3 aree di attenzione che analizzeremo, che integrano teoria e pratica, e che possono aiutarti a trasformare le relazioni che hai con i tuoi figli. 1. Genitore falegname VS Genitore giardiniere"Rispetta la natura unica di ogni figlio invece di proiettare le tue aspettative"2. Il concetto di conto corrente emotivo"La sicurezza emotiva si costruisce attraverso depositi quotidiani costanti"3. L'importanza di collezionare esperienze, non oggetti"Le memorie condivise sono il vero patrimonio relazionale"Io ti aspetto lunedì, riserva il tuo posto qui: https://store.psicologo-milano.it/webinar-genitorialita-23-giugno#genitorialità #genitore #crescitapersonale #psicologia

Need any advice or information, message us.I sat down with Jake Alexander, founder of Tucan.IO—a WhatsApp translation tool designed to help expats and locals bridge the language gap between English and Tico Spanish. We discussed how the idea for Tucan.IO came about and the ways it's helping expats navigate daily communication in Costa Rica. Jake also shared his thoughts on current market conditions, including which areas he sees potential in and which ones he's avoiding for now.Free 15 min consultation:  https://meetings.hubspot.com/jake806/crconsultContact us: info@investingcostarica.comTucan.io: https://tucanchat.io/

Il film con il comico Angelo Duro "Io sono la fine del mondo" dopo i notevoli incassi al cinema sbarca su Netflix e continua a riscuotere successo. Proviamo a capire le ragioni del trionfo del campione del politicamente scorretto con l'aiuto del nostro pubblico.

In this episode of Crack the Book, we take a look at Week Fourteen of Ted Gioia's Humanities Course, covering Virgil's The Aeneid (Books 1–2), Ovid's Metamorphoses (Book 1), and selections from The Portable Roman Reader. The focus is on key texts from Roman literature, their historical context, and their connections to earlier Greek works, providing an overview of their content and significance.Key Discussion Points: Virgil's The Aeneid (Robert Fagles' Translation): Written between 29–19 BCE, The Aeneid serves as Rome's foundational epic, modeled on Homer's Iliad and Odyssey. Book 1 opens with Aeneas, a Trojan survivor, shipwrecked on Carthage's shore due to Juno's interference, meeting Queen Dido, an exile from Tyre. Book 2 recounts Troy's fall, including the Trojan Horse stratagem and Aeneas' escape with his father Anchises and son Ascanius, losing his wife Creusa. The text emphasizes Aeneas' pietas (duty to gods, family, state). Divine rivalries, notably Juno's grudge from the Judgment of Paris and Venus' protection of Aeneas, drive the narrative. The Fagles translation includes maps and a glossary for accessibility. Ovid's Metamorphoses (David Raeburn's Translation): Composed around 8 CE, Metamorphoses is a 15-book poem chronicling transformations from creation to Ovid's era. Book 1 covers the creation of the cosmos from Chaos, the division into four elements (fire, water, earth, air), and humanity's decline from the Golden to Iron Age. It includes a flood narrative with Deucalion and Pyrrha and the story of Io, transformed into a cow by Jupiter to evade Juno. The Raeburn edition organizes vignettes with titled sections for clarity. The Portable Roman Reader (Basil Davenport, Ed.): Published in 1951, this anthology includes poetry from Rome's Republic, Augustan, and later Empire periods. Catullus (c. 60s–50s BCE) offers direct, personal verses, translated by Byron. Horace (65–8 BCE) writes complex, philosophical odes, less accessible due to style. Martial (c. 38–104 CE) provides epigrams on public life, including two elegies for a deceased young girl. Davenport's notes contextualize each era, and the anthology features prose by Livy, Caesar, and Tacitus for future study. Contextual Notes: The texts reflect Rome's engagement with Greek literary traditions, adapting gods' names (e.g., Hera to Juno) and themes. The course's schedule prioritizes rapid coverage to identify key works and connections.Takeaways:I loved this week so much! It felt great to come "home" to Rome. I've got specific ideas about how to approach each of these books, but in my opinion they are all worth the time for certain people. The music was gorgeous, arias and overtures from Puccini and Verdi! You must listen...check out my link below. And the cave paintings were worth examining as well, especially the handprints from Indonesia. See that link below, too.This is a year-long challenge! Join me next week for WHATEVER IS NEXTLINKSTed Gioia/The Honest Broker's 12-Month Immersive Humanities Course (paywalled!)My Amazon Book List (NOT an affiliate link)Spotify Play List of Puccini and Verdi without wordsCave...

In this episode of Talking Drupal, we delve into the International Drupal Federation Initiative with our guest Tim Doyle, CEO of the Drupal Association. We explore the goals, structure, and potential impact of this initiative on the global Drupal community. Additionally, we cover the Modeler API as our module of the week, discussing its functionalities and future potential. Joining the discussion are hosts John Picozzi, Norah Medlin, Nic Laflin, and Martin Anderson-Clutz, who bring their insights and perspectives to the table. For show notes visit: https://www.talkingDrupal.com/507 Topics Meet the Guest: Tim Doyle Module of the Week: Modeler API Deep Dive into Modeler API Introducing the International Drupal Federation Initiative Governance and Global Impact Challenges and Future Prospects Annual Meeting and Governance Structure Challenges in Crafting Agreements Local Associations and Their Needs Engagement and Communication Strategies Regional Organizations and Governance US-Based Not-for-Profit Focus International Federation and Local Support Potential Risks and Governance Models Implementation Timeline and Costs Legal and Organizational Considerations Community Involvement and Feedback Conclusion and Contact Information Resources International Drupal Federation Initiative Recent DA Video Feature on The Drop Times ASBL Guests Tim Doyle - Drupal.org Tim D. Hosts Nic Laflin - nLighteneddevelopment.com nicxvan John Picozzi - epam.com johnpicozzi Norah Medlin - tekNorah Module of the Week with Martin Anderson-Clutz - mandclu.com mandclu Modeler API The Modeler API provides an API for modules like ECA - Events, Conditions, Actions, Migrate Visualize, AI Agents, and maybe others. The purpose is to allow those modules to utilize modelers like BPMN.iO, (and maybe others in the future) to build diagrams constructed of their components (e.g. plugins) and write them back into module-specific config entities.

Apple's WWDC and Google I/O have both come and gone, and... well, we took a look at I/O and it was practically all AI this year, so we skipped that. But Apple's annual developer's conference was surprisingly light on AI features -- in fact, the continuing absence of the AI-driven Siri and other features announced last year is itself a notable story -- so this week we recapped what Apple brought to WWDC instead, including its first major UI refresh in a decade, interesting additions to smaller stuff like Wallet and Shortcuts, the ever-more-laptop-like nature of the iPad, the end of x86 support and beginning of annual versioning for MacOS, and a bunch of other stuff. Support the Pod! Contribute to the Tech Pod Patreon and get access to our booming Discord, a monthly bonus episode, your name in the credits, and other great benefits! You can support the show at: https://patreon.com/techpod

We spent the week learning keybindings, installing dependencies, and cramming for bonus points. Today, we score up and see how we did in the TUI Challenge.Sponsored By:Tailscale: Tailscale is a programmable networking software that is private and secure by default - get it free on up to 100 devices! 1Password Extended Access Management: 1Password Extended Access Management is a device trust solution for companies with Okta, and they ensure that if a device isn't trusted and secure, it can't log into your cloud apps. Unraid: A powerful, easy operating system for servers and storage. Maximize your hardware with unmatched flexibility. Support LINUX UnpluggedLinks:

In this episode of The Birth Trauma Mama Podcast, I'm joined by Francine and Matt for an emotional retelling of their son's birth, a story that began with a calm, well-planned birth center experience and ended in a series of life-threatening emergencies, including a transfer to the hospital, an emergency C-section, a postpartum hemorrhage, and an amniotic fluid embolism (AFE).With honesty, heartbreak, and even humor, Francine and Matt walk us through their experience of navigating a medical system that left them unsupported, uninformed, and at times, in the dark. Francine shares what it was like to lose nine days of memory after nearly dying in the ICU, and Matt shares what it felt like to be the sole caregiver to their newborn while fearing he might lose his wife.This conversation is an important reminder of how critical communication and advocacy are and how families carry these experiences long after leaving the hospital.What You'll Hear in This Episode:

Support the pod! ⁠Join our Patreon ⁠for weekly bonus episodes and TONS of exclusive premium content⁠Join the Discord community⁠Dive into our discord channel to connect with fellow fans, discuss your favorite episodes, and meet the hosts of the show!It's that good good improv slop that the perverts love! This week with chat'n'prov with Trent Dozier and Jesse Kendall about all thing thrifty, spooky, Soprano and more! More bad impressions for us to really sink our fangs into. This will make sense once you listen.Huge thanks to Nick McMillin for the editing help on this one. Knocked it out of the park! Also another thanks to Dtrain389 for their opening scene request. I think we accidentally did double Dtrain request because of the release order, we promise we're not purposely neglecting other scene requests!If you're looking to see us LIVE, you can June 24th at 8 pm at iO with Jesse and Erin Keif! Grab a ticket below and use code FUDGEFRIEND for a discount!If you're in LA make sure you go see Mandatory Improv Thursdays nights at 7 pm at The Yard before the Yard closes its doors later this summer!Check out Jesse in his movie Love Dump on Prime!Performers:Trent DozierJesse KendallHosts:⁠ ⁠Damian Anaya⁠⁠,⁠ ⁠Tim Lyons⁠⁠, and⁠ ⁠Dan White⁠⁠

Based on feedback from last week this might just be a car podcast now, but we also discuss the Switch 2 launch news that's starting to trickle out, Brad's deep dive into Elden Ring Nightreign, details on EA's cancelled Black Panther game, new footage from The Witcher 4, some questionably timed State of Play predictions, and more. CHAPTERS (00:00:00) NOTE: Some timecodes may be inaccurate for versions other than the ad-free Patreon version due to dynamic ad insertions. Please use caution if skipping around to avoid spoilers. Thanks for listening. (00:00:10) Intro (00:01:16) The Switch 2 is out in the wild and on the internet (00:06:01) Yes, for the Wii Wii (00:07:03) If you hear something, say something (00:08:18) Dogs are gonna chase squirrels if you let them! (00:10:45) Elden Ring: Nightreign  |  [PC (Microsoft Windows), Xbox One, PlayStation 4, PlayStation 5, Xbox Series X|S]  |  May 30, 2025 (00:40:57) First Break (00:43:42) Date Everything!  |  [PC (Microsoft Windows), Nintendo Switch, PlayStation 5, Xbox Series X|S]  |  Jun 17, 2025 (00:51:44) Clair Obscur: Expedition 33  |  [PC (Microsoft Windows), PlayStation 5, Xbox Series X|S]  |  Apr 24, 2025 (00:59:22) Hollow Knight  |  [Linux, PC (Microsoft Windows)]  |  Feb 24, 2017 (01:02:52) Second Break (01:02:57) News (01:03:37) The Switch 2 is here (01:09:01) Summer Game Fest and Not-E3 happenings (01:12:29) IO's new James Bond game has a title (01:18:03) The Witcher 4 and Unreal Engine 5 (01:26:53) More reporting on EA canceling its Black Panther game (01:33:34) Emails OR more a summary of the car emails we have received (01:51:52) Nextlander content updates (01:54:37) Wrapping up and thanks (01:58:56) Mysterious Benefactor Shoutouts (02:02:02) Our Switch 2 and Summer Game Fest plans (02:04:33) See ya!

Go to http://kindafunny.com/XREAL to grab yours now! IO's James Bond game has an official title, we're going to see more The Witcher 4 tomorrow, and the Hi-Fi Rush studio is hiring for a new action game. Thank you for the support! Run of Show - - Start - Housekeeping We're throwing a SWITCH 2 LAUNCH PARTY Today after, KFGD, you'll get: If you're a Kinda Funny Member: The Roper Report   - - James Bond Game From Hitman Dev Has a New Title, 007 First Light, Official Reveal This Week - Ad - The Witcher 4's Unreal Engine 5 In-Game Features and Technology Set to Be Revealed Tomorrow - Hi-Fi Rush Dev Tango Gameworks 'Remains Dedicated to Distinctive and New IPs,' as It Starts Hiring for New Action Game - Wizards of the Coast signs publishing agreement with Giant Skull - Wee News! - SuperChats & You‘re Wrong Learn more about your ad choices. Visit megaphone.fm/adchoices